| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIFBP MAP1A MAP1B EPB41L4A DYSF ADD1 ALMS1 MYO18B VCL ROCK2 FLNB CLXN ANK2 ANK3 NRCAM ABI3BP POLB PPP1R9A WASHC1 SMTNL1 MACF1 ROCK1 LSP1 TNNT3 SKA1 | 4.30e-05 | 1099 | 189 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | chromatin binding | CHD4 HP1BP3 PWWP2A TNRC18 NFATC3 SUPT6H NKAP TAF5 ATRN ZC3H12A KAT6A CHD8 UPF1 RING1 NCOR1 NCOR2 PELP1 CTCF SMARCA1 | 7.93e-05 | 739 | 189 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 8.91e-05 | 2 | 189 | 2 | GO:0072518 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 NES KIFBP HECW1 MAP1A MAP1B MYCBP2 RREB1 PTPRF EIF2B2 VCL ROCK2 ANK3 NRCAM ABI3BP JADE2 PPP1R9A CREB1 RUFY3 KIAA1755 MACF1 ROCK1 SNX2 | 1.49e-06 | 826 | 185 | 23 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 NES KIFBP HECW1 MAP1A MAP1B MYCBP2 RREB1 ADD1 PTPRF EIF2B2 VCL ROCK2 FLNB ANK3 NRCAM ABI3BP JADE2 PPP1R9A ARHGEF18 CREB1 RUFY3 FRY KIAA1755 MACF1 ROCK1 ARHGAP18 SNX2 | 2.91e-06 | 1194 | 185 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 KIFBP HECW1 MAP1A MAP1B MYCBP2 RREB1 PTPRF EIF2B2 VCL ROCK2 ANK3 NRCAM ABI3BP JADE2 PPP1R9A CREB1 RUFY3 KIAA1755 MACF1 ROCK1 SNX2 | 4.56e-06 | 819 | 185 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | NES MAP1A MAP1B MYCBP2 DYSF ADD1 ALMS1 ROCK2 PPP1R9A WASHC1 ARHGEF18 WASHC3 STIL ARHGEF10L ROCK1 AKAP13 ARHGAP18 SKA1 | 5.00e-06 | 579 | 185 | 18 | GO:0051493 |
| GeneOntologyBiologicalProcess | neuron development | CHL1 KIFBP HECW1 MAP1A MAP1B MYCBP2 CYTH2 PCDH12 SLC12A5 ALMS1 PTPRF EIF2B2 SECISBP2 CNGB1 VCL ROCK2 SLC4A7 ANK3 NRCAM ABI3BP ADAMTS1 JADE2 TNC PPP1R9A CREB1 RUFY3 FRY KIAA1755 MACF1 ROCK1 | 1.75e-05 | 1463 | 185 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | developmental growth | MAP1B MYCBP2 DYSF ADD1 SLC12A5 ALMS1 EIF2B2 PKM VCL ATRN NRCAM JADE2 TNC STIL CREB1 RUFY3 NCOR1 KMT2D ANKRD11 MACF1 AKAP13 PAX7 | 2.39e-05 | 911 | 185 | 22 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 2.71e-05 | 20 | 185 | 4 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 2.71e-05 | 20 | 185 | 4 | GO:1903140 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | KIFBP ERF SPEG NASP PCDH12 ADD1 SUPT6H MYO18B POLB CHD8 STIL NCOR1 NCOR2 KMT2D CTCF ANKRD11 FLCN | 2.79e-05 | 596 | 185 | 17 | GO:0001701 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 KIFBP HECW1 MAP1A MAP1B MYCBP2 PTPRF EIF2B2 VCL ROCK2 ANK3 NRCAM ABI3BP JADE2 PPP1R9A CREB1 RUFY3 KIAA1755 MACF1 ROCK1 | 3.67e-05 | 802 | 185 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | CYTH2 EPB41L4A ADD1 ALMS1 MYO18B ROCK2 FLNB ABI3BP PPP1R9A WASHC1 ARHGEF18 WASHC3 BCAR1 RUFY3 ARHGEF10L SMTNL1 ROCK1 AKAP13 ARHGAP18 TNNT3 | 3.74e-05 | 803 | 185 | 20 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | MAP1A MAP1B DYSF ADD1 ALMS1 ROCK2 PPP1R9A WASHC1 ARHGEF18 WASHC3 ARHGEF10L ROCK1 AKAP13 ARHGAP18 | 4.34e-05 | 438 | 185 | 14 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MAP1B IRAG1 ADD1 HP1BP3 SLC12A5 EIF2B2 ROCK2 HTR2C NRCAM PPP1R9A WASHC1 CREB1 RUFY3 SMTNL1 MACF1 ROCK1 ARHGAP18 | 4.39e-05 | 618 | 185 | 17 | GO:0090066 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | EPB41L4A ALMS1 MYO18B ROCK2 PPP1R9A ARHGEF18 ARHGEF10L ROCK1 AKAP13 TNNT3 | 6.23e-05 | 239 | 185 | 10 | GO:0031032 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | MAP1A MAP1B DRC1 DYSF ALMS1 ROCK2 CLXN STIL MACF1 ROCK1 SKA1 | 7.12e-05 | 293 | 185 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | actin filament-based process | CYTH2 EPB41L4A ADD1 ALMS1 MYO18B ROCK2 FLNB ANK2 ABI3BP PPP1R9A WASHC1 ARHGEF18 WASHC3 BCAR1 RUFY3 ARHGEF10L SMTNL1 ROCK1 AKAP13 ARHGAP18 TNNT3 | 7.32e-05 | 912 | 185 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 KIFBP HECW1 MAP1A MAP1B MYCBP2 CYTH2 SLC12A5 ALMS1 PTPRF EIF2B2 VCL ROCK2 ANK3 NRCAM ABI3BP ADAMTS1 JADE2 TNC PPP1R9A CREB1 RUFY3 FRY KIAA1755 MACF1 ROCK1 | 8.45e-05 | 1285 | 185 | 26 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 1.17e-04 | 122 | 185 | 7 | GO:0110020 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 KIFBP HECW1 MAP1A MAP1B MYCBP2 PTPRF EIF2B2 VCL ROCK2 ANK3 NRCAM ABI3BP PPP1R9A CREB1 RUFY3 KIAA1755 MACF1 | 1.43e-04 | 748 | 185 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 1.71e-04 | 58 | 185 | 5 | GO:0061028 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 2.35e-04 | 34 | 185 | 4 | GO:0090311 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | NASP CHD4 GTF3C4 HP1BP3 PWWP2A SUPT6H TAF5 JADE2 KAT6A CHD8 CREB1 RING1 KANSL3 NCOR1 TGM2 KMT2D CTCF BRD9 SMARCA1 PAX7 TP53BP1 | 2.57e-04 | 999 | 185 | 21 | GO:0071824 |
| GeneOntologyBiologicalProcess | growth | MAP1B MYCBP2 DYSF ADD1 SLC12A5 ALMS1 EIF2B2 PKM VCL ATRN NRCAM JADE2 TNC STIL BCAR1 CREB1 RUFY3 NCOR1 KMT2D ANKRD11 MACF1 CCAR2 AKAP13 PAX7 | 2.95e-04 | 1235 | 185 | 24 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | HECW1 MAP1B ADGRB2 RREB1 ADD1 SARS1 PTPRF NFATC3 EIF2B2 PKM ROCK2 ZC3H12A ABI3BP ADAMTS1 PPP1R9A ARHGEF18 RUFY3 TGM2 GTF2I MACF1 ROCK1 ARHGAP18 | 3.20e-04 | 1090 | 185 | 22 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ERF ETV3 CHD4 RREB1 MAGEB10 SARS1 NFATC3 FNIP1 TIMELESS NKAP ZBTB33 FOSB KAT6A CC2D1B CHD8 CREB1 RING1 CRY2 NCOR1 NCOR2 SMTNL1 CTCF FLCN CCAR2 VSX2 SPEN | 3.24e-04 | 1399 | 185 | 26 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ERF ETV3 CHD4 RREB1 MAGEB10 SARS1 NFATC3 FNIP1 TIMELESS NKAP ZBTB33 FOSB KAT6A CC2D1B CHD8 CREB1 RING1 CRY2 NCOR1 NCOR2 SMTNL1 CTCF FLCN CCAR2 VSX2 SPEN | 3.78e-04 | 1413 | 185 | 26 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | ADD1 ALMS1 ROCK2 PPP1R9A WASHC1 ARHGEF18 WASHC3 ARHGEF10L ROCK1 ARHGAP18 | 3.94e-04 | 300 | 185 | 10 | GO:0110053 |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 4.10e-04 | 107 | 185 | 6 | GO:0051492 | |
| GeneOntologyBiologicalProcess | chromatin organization | NASP CHD4 GTF3C4 HP1BP3 PWWP2A SUPT6H JADE2 KAT6A CHD8 RING1 KANSL3 NCOR1 TGM2 KMT2D CTCF BRD9 SMARCA1 PAX7 TP53BP1 | 4.60e-04 | 896 | 185 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | negative regulation of lysosome organization | 4.74e-04 | 4 | 185 | 2 | GO:1905672 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 4.74e-04 | 4 | 185 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MAP1B ADD1 HP1BP3 SLC12A5 EIF2B2 NRCAM PPP1R9A WASHC1 CREB1 RUFY3 MACF1 ARHGAP18 | 4.85e-04 | 426 | 185 | 12 | GO:0032535 |
| GeneOntologyBiologicalProcess | embryo development | NES KIFBP ERF SPEG NASP PCDH12 ADD1 SUPT6H TIMELESS MYO18B ROCK2 VTN POLB KAT6A CHD8 STIL NCOR1 NCOR2 KMT2D GTF2I CTCF ANKRD11 FLCN MACF1 ROCK1 PAX7 | 4.87e-04 | 1437 | 185 | 26 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | MAP1B MYCBP2 ADGRB2 CHD4 VCL ROCK2 ABI3BP PPP1R9A MACF1 ROCK1 | 4.96e-04 | 309 | 185 | 10 | GO:1901888 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ERF ETV3 CHD4 RREB1 MAGEB10 SARS1 NFATC3 FNIP1 TIMELESS NKAP ZBTB33 FOSB CC2D1B CHD8 CRY2 NCOR1 NCOR2 CTCF FLCN VSX2 SPEN | 5.15e-04 | 1053 | 185 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of connective tissue replacement | 5.25e-04 | 18 | 185 | 3 | GO:1905203 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | KIFBP ERF SPEG NASP PCDH12 ADD1 SUPT6H MYO18B ROCK2 POLB CHD8 STIL NCOR1 NCOR2 KMT2D CTCF ANKRD11 FLCN PAX7 | 5.26e-04 | 906 | 185 | 19 | GO:0043009 |
| GeneOntologyCellularComponent | costamere | 3.55e-08 | 22 | 191 | 6 | GO:0043034 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP1A MAP1B CYTH2 RTN1 ADD1 SLC12A5 PTPRF GRIN3B ROCK2 ANK2 ANK3 NRCAM ABI3BP PPP1R9A CAST GRM5 MACF1 | 3.99e-06 | 503 | 191 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | asymmetric synapse | MAP1A MAP1B CHD4 RTN1 ADD1 PTPRF GRIN3B ROCK2 ANK2 ANK3 NRCAM ABI3BP PPP1R9A CAST GRM5 MACF1 | 8.52e-06 | 477 | 191 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | MAP1A MAP1B RTN1 ADD1 PTPRF GRIN3B ROCK2 ANK2 ANK3 NRCAM ABI3BP PPP1R9A CAST GRM5 MACF1 | 1.81e-05 | 451 | 191 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP1A MAP1B CHD4 RTN1 ADD1 PTPRF GRIN3B ROCK2 ANK2 ANK3 NRCAM ABI3BP PPP1R9A CAST GRM5 MACF1 | 2.64e-05 | 523 | 191 | 16 | GO:0098984 |
| GeneOntologyCellularComponent | chromatin | ERF ETV3 NASP CHD4 HP1BP3 NFATC3 TIMELESS TAF5 MGA ZBTB33 JADE2 FOSB KAT6A CHD8 UPF1 CREB1 RAX RING1 KANSL3 NCOR1 TGM2 NCOR2 PELP1 BRD9 SMARCA1 ANKRD11 ZFHX2 CCAR2 PAX7 VSX2 | 3.16e-05 | 1480 | 191 | 30 | GO:0000785 |
| GeneOntologyCellularComponent | lamellipodium | DYSF ARHGAP31 SH3RF1 ABI3BP PPP1R9A WASHC1 BCAR1 RUFY3 ROCK1 SNX2 | 5.29e-05 | 230 | 191 | 10 | GO:0030027 |
| GeneOntologyCellularComponent | cell leading edge | CYTH2 DYSF SLC12A5 ARHGAP31 SH3RF1 ABI3BP PPP1R9A WASHC1 AAK1 BCAR1 RUFY3 MACF1 ROCK1 ARHGAP18 SNX2 | 5.91e-05 | 500 | 191 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 6.42e-05 | 75 | 191 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | myofibril | 2.16e-04 | 273 | 191 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.50e-04 | 290 | 191 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | methyltransferase complex | 4.76e-04 | 108 | 191 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | sarcomere | 4.92e-04 | 249 | 191 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | T-tubule | 7.88e-04 | 79 | 191 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | I band | 8.52e-04 | 166 | 191 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ADD1 AHNAK MYO18B TAF5 VCL FLNB PPP1R9A BCAR1 SMTNL1 EFR3B MACF1 AKAP13 LSP1 TNNT3 | 8.69e-04 | 576 | 191 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | transcription repressor complex | 1.22e-03 | 87 | 191 | 5 | GO:0017053 | |
| GeneOntologyCellularComponent | anchoring junction | CYTH2 KIRREL2 PCDH12 ADD1 SMPX GJA8 FNDC1 ARHGAP31 AHNAK VCL FLNB HYOU1 ANK2 ANK3 TNC BCAR1 RUFY3 TGM2 FLCN | 1.58e-03 | 976 | 191 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.72e-03 | 94 | 191 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ESS2 CWC27 ETV3 CHD4 CXXC1 SUPT6H BOD1L1 TIMELESS TAF5 MGA CASC3 CHD8 MSH3 UPF1 CREB1 RING1 CRY2 NCOR1 NCOR2 KMT2D PELP1 BRD9 SMARCA1 CSTF3 | 1.76e-03 | 1377 | 191 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | axon initial segment | 2.30e-03 | 29 | 191 | 3 | GO:0043194 | |
| Domain | Rho_Binding | 1.04e-04 | 2 | 191 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 1.04e-04 | 2 | 191 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 1.04e-04 | 2 | 191 | 2 | IPR020684 | |
| Domain | N-CoR_GPS2_interact | 1.04e-04 | 2 | 191 | 2 | IPR031557 | |
| Domain | GPS2_interact | 1.04e-04 | 2 | 191 | 2 | PF15784 | |
| Domain | FN3 | 1.24e-04 | 185 | 191 | 9 | SM00060 | |
| Domain | fn3 | 2.67e-04 | 162 | 191 | 8 | PF00041 | |
| Domain | FN3_dom | 3.09e-04 | 209 | 191 | 9 | IPR003961 | |
| Domain | MAP1 | 3.10e-04 | 3 | 191 | 2 | IPR026074 | |
| Domain | OAR | 5.34e-04 | 16 | 191 | 3 | PS50803 | |
| Domain | OAR_dom | 5.34e-04 | 16 | 191 | 3 | IPR003654 | |
| Domain | Neurofascin/L1/NrCAM_C | 6.16e-04 | 4 | 191 | 2 | IPR026966 | |
| Domain | LRRC37AB_C | 6.16e-04 | 4 | 191 | 2 | IPR029423 | |
| Domain | LRRC37AB_C | 6.16e-04 | 4 | 191 | 2 | PF14914 | |
| Domain | Bravo_FIGEY | 6.16e-04 | 4 | 191 | 2 | PF13882 | |
| Domain | LRRC37_N | 6.16e-04 | 4 | 191 | 2 | IPR032754 | |
| Domain | LRRC37 | 6.16e-04 | 4 | 191 | 2 | PF15779 | |
| Domain | LRRC37A/B-like | 6.16e-04 | 4 | 191 | 2 | IPR015753 | |
| Domain | FerI | 1.02e-03 | 5 | 191 | 2 | SM01202 | |
| Domain | FerB | 1.02e-03 | 5 | 191 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.02e-03 | 5 | 191 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.02e-03 | 5 | 191 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.02e-03 | 5 | 191 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.02e-03 | 5 | 191 | 2 | IPR012968 | |
| Domain | FerI | 1.02e-03 | 5 | 191 | 2 | PF08151 | |
| Domain | FerB | 1.02e-03 | 5 | 191 | 2 | PF08150 | |
| Domain | Anion_exchange | 1.02e-03 | 5 | 191 | 2 | IPR001717 | |
| Domain | PHD | 1.03e-03 | 75 | 191 | 5 | PF00628 | |
| Domain | FN3 | 1.04e-03 | 199 | 191 | 8 | PS50853 | |
| Pubmed | NES KIFBP HECW1 MYCBP2 CYTH2 ADGRB2 CHD4 LMTK3 RTN1 ADD1 SLC12A5 NFATC3 TAF5 MGA WNK2 ROCK2 CASC3 ANK2 ANK3 NRCAM PPP1R9A AAK1 ARHGEF18 CHD8 UPF1 GRM5 NCOR1 NCOR2 FRY UBE2O PELP1 CTCF MACF1 ROCK1 CCAR2 TP53BP1 | 2.68e-19 | 963 | 198 | 36 | 28671696 | |
| Pubmed | RAPGEF6 MAP1B MYCBP2 NASP GTF3C4 ADD1 ALMS1 AHNAK PKM BOD1L1 TAF5 MGA VCL ZBTB33 ANK3 CAST CHD8 UPF1 NCOR1 UBE2O KMT2D GTF2I SPEN SNX2 TP53BP1 | 1.45e-15 | 549 | 198 | 25 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 RAPGEF6 MAP1A MAP1B NASP CHD4 RTN1 KIAA1143 GTF3C4 ADD1 HP1BP3 ALMS1 AHNAK PKM BOD1L1 ACBD3 VCL ZBTB33 ANK2 COPB1 U2SURP CAST AAK1 UPF1 UBE2O GTF2I CTCF MACF1 TP53BP1 AHNAK2 FTSJ3 | 2.77e-15 | 934 | 198 | 31 | 33916271 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | CHD4 RREB1 GTF3C4 SARS1 AHNAK PKM BOD1L1 FLNB ZBTB33 CAST CHD8 MSH3 UPF1 NCOR1 GTF2I PELP1 CCAR2 TP53BP1 AHNAK2 | 7.71e-14 | 332 | 198 | 19 | 32786267 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERICH1 ESS2 CWC27 NASP CHD4 RREB1 KIAA1143 GTF3C4 HP1BP3 PWWP2A SGO2 BOD1L1 TIMELESS MGA REXO4 KAT6A CHD8 MSH3 RING1 UBE2O GTF2I BRD9 SMARCA1 SPEN | 1.24e-13 | 608 | 198 | 24 | 36089195 |
| Pubmed | NES MAP1B MYCBP2 CHD4 HP1BP3 SUPT6H AHNAK VCL FLNB REXO4 HYOU1 COPB1 U2SURP CHD8 UPF1 UBE2O GTF2I PELP1 CTCF MACF1 CCAR2 SPEN TP53BP1 FTSJ3 | 5.70e-13 | 653 | 198 | 24 | 22586326 | |
| Pubmed | ERICH1 PALD1 NES ESS2 MYCBP2 RREB1 RTN1 GTF3C4 ADD1 ALMS1 SECISBP2 BOD1L1 MGA ACBD3 VCL CASC3 SLC4A7 ZBTB33 HYOU1 ARHGEF18 TGM2 UBE2O ROCK1 CCAR2 AKAP13 | 9.37e-13 | 733 | 198 | 25 | 34672954 | |
| Pubmed | PALD1 MAP1B ADD1 AHNAK PKM BOD1L1 VCL ROCK2 FLNB ZBTB33 HYOU1 SH3RF1 ANK2 ANK3 COPB1 AAK1 ABCC5 CC2D1B UPF1 RABL6 EFR3B MACF1 ROCK1 | 2.15e-11 | 708 | 198 | 23 | 39231216 | |
| Pubmed | ERICH1 ERF CALHM1 KIAA0319L CHD4 ADD1 HP1BP3 AHNAK PKM MGA REXO4 SLC4A7 ZBTB33 ANK3 COPB1 TMEM115 ABCC5 RUFY3 RABL6 NCOR1 LIPE GTF2I CCAR2 SPEN | 2.17e-11 | 777 | 198 | 24 | 35844135 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | CLPP ERF RREB1 TNRC18 ALMS1 MGA ALDH5A1 HYOU1 CHD8 MSH3 RING1 NCOR1 NCOR2 KMT2D BRD9 SMARCA1 SPEN | 2.33e-11 | 351 | 198 | 17 | 38297188 |
| Pubmed | ESS2 ERF ETV3 RREB1 CXXC1 HP1BP3 ALMS1 NFATC3 TAF5 MGA VCL REXO4 ZBTB33 COPB1 CHD8 UPF1 CREB1 RING1 KANSL3 NCOR1 NCOR2 UBE2O KMT2D GTF2I CTCF BRD9 SMARCA1 CCAR2 PAX7 SPEN TP53BP1 FTSJ3 | 3.57e-11 | 1429 | 198 | 32 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 RAPGEF6 MYCBP2 SPEG KIAA0319L ADGRB2 DYSF SLC38A10 TNRC18 PTPRF AHNAK AP1G2 WNK2 SH3RF1 KAT6A KTI12 CHD8 ARHGEF10L KANSL3 RABL6 NCOR1 NCOR2 KMT2D ANKRD11 FLCN AKAP13 SPEN AHNAK2 | 4.21e-11 | 1105 | 198 | 28 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES MAP1B MYCBP2 CHD4 CXXC1 GTF3C4 GRHPR AHNAK PKM AP1G2 MGA VCL FLNB REXO4 COPB1 U2SURP AAK1 CHD8 MSH3 UPF1 RING1 TGM2 NCOR2 GTF2I SMARCA1 MACF1 CCAR2 AKAP13 TP53BP1 AHNAK2 FTSJ3 | 4.26e-11 | 1353 | 198 | 31 | 29467282 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | MAP1B CHD4 RREB1 HP1BP3 MGA CASC3 REXO4 ZBTB33 UPF1 RING1 GTF2I PELP1 CTCF SMARCA1 CCAR2 FTSJ3 | 2.06e-10 | 349 | 198 | 16 | 25665578 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MAP1B CHD4 RREB1 HP1BP3 AHNAK SGO2 BOD1L1 MGA REXO4 ZBTB33 U2SURP CAST CHD8 CREB1 NCOR1 NCOR2 GTF2I PELP1 CTCF BRD9 ANKRD11 CSTF3 SPEN TP53BP1 FTSJ3 | 2.55e-10 | 954 | 198 | 25 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP1B MYCBP2 HP1BP3 TNRC18 SUPT6H FNIP1 BOD1L1 WNK2 ATRN CASC3 FLNB ANK3 JADE2 PPP1R9A KAT6A CAST AAK1 ARHGEF18 WASHC3 BCAR1 KANSL3 NCOR2 TRNT1 GTF2I ANKRD11 CSTF3 ZFHX2 MACF1 AKAP13 MCTP2 SNX2 | 4.45e-10 | 1489 | 198 | 31 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAPGEF6 ESS2 SPATA31E1 MAP1A LMTK3 TNRC18 ARHGAP31 MGA WNK2 ANK3 ARHGEF18 BCAR1 NCOR1 NCOR2 AKAP13 PAX7 SPEN | 5.35e-10 | 430 | 198 | 17 | 35044719 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPGEF6 MYCBP2 NASP CHD4 RREB1 GTF3C4 ADD1 PASK TIMELESS NKAP ROCK2 CAST AAK1 KANSL3 NCOR1 NCOR2 KMT2D GTF2I CCAR2 SPEN SNX2 TP53BP1 | 7.40e-10 | 774 | 198 | 22 | 15302935 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MAP1A ALMS1 ARHGAP31 MGA U2SURP ARHGEF18 STIL NCOR1 NCOR2 KMT2D CCAR2 SPEN | 7.69e-10 | 184 | 198 | 12 | 32908313 |
| Pubmed | MAP1B TTC16 CWC27 CHD4 CXXC1 FER1L6 HP1BP3 TNRC18 AHNAK PKM BOD1L1 DNAH8 ROCK2 FLNB HYOU1 ANK2 ABI3BP COL20A1 U2SURP PPP1R9A ABCC5 CC2D1B SLC4A3 RING1 NCOR1 TRNT1 SMARCA1 MACF1 CCAR2 SPEN | 8.96e-10 | 1442 | 198 | 30 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A MAP1B MYCBP2 CWC27 DYSF ADD1 SARS1 AHNAK SECISBP2 MGA VCL REXO4 HYOU1 CAST AAK1 UPF1 BRD9 MACF1 AKAP13 SPEN AHNAK2 | 1.29e-09 | 724 | 198 | 21 | 36232890 |
| Pubmed | CHD4 CXXC1 HP1BP3 SUPT6H AHNAK BOD1L1 NKAP CHD8 KMT2D CTCF SMARCA1 SPEN TP53BP1 | 2.50e-09 | 251 | 198 | 13 | 31076518 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIFBP ESS2 MAP1B CHD4 GTF3C4 PKM MGA SLC4A7 ZBTB33 FOSB MSH3 CREB1 KANSL3 NCOR1 NCOR2 KMT2D PELP1 SMARCA1 CCAR2 SPEN SNX2 TP53BP1 | 4.76e-09 | 857 | 198 | 22 | 25609649 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ESS2 MAP1A MAP1B GTF3C4 AHNAK PKM MGA ZBTB33 AAK1 CHD8 UPF1 KANSL3 NCOR1 NCOR2 GTF2I AHNAK2 | 6.54e-09 | 444 | 198 | 16 | 34795231 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYCBP2 CHD4 GTF3C4 HP1BP3 GJA8 GRHPR AHNAK PKM VCL FLNB HYOU1 ANK3 COPB1 CHD8 UPF1 TGM2 GOLPH3L MACF1 AKAP13 ARHGAP18 AHNAK2 | 8.62e-09 | 807 | 198 | 21 | 30575818 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ESS2 NASP CHD4 RREB1 ADD1 HP1BP3 AHNAK PKM NKAP TAF5 CASC3 HYOU1 COPB1 U2SURP CHD8 UPF1 KANSL3 RABL6 NCOR1 TGM2 TRNT1 GTF2I PRG2 BRD9 CCAR2 SNX2 FTSJ3 | 9.41e-09 | 1318 | 198 | 27 | 30463901 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NES MAP1B MYCBP2 NASP CHD4 ADD1 SARS1 AHNAK PKM ACBD3 VCL FLNB HYOU1 ANK3 COPB1 ADAMTS1 U2SURP CAST UPF1 UBE2O GTF2I MACF1 CCAR2 SNX2 FTSJ3 | 1.09e-08 | 1149 | 198 | 25 | 35446349 |
| Pubmed | NES MAP1A MAP1B CYTH2 RTN1 ADD1 HP1BP3 SLC12A5 SARS1 PKM WNK2 VCL ROCK2 FLNB HYOU1 ANK2 ANK3 NRCAM COPB1 TNC PPP1R9A AAK1 UPF1 GRM5 RUFY3 UBE2O MACF1 SNX2 | 1.30e-08 | 1431 | 198 | 28 | 37142655 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KIFBP NASP GTF3C4 SARS1 AHNAK EIF2B2 PKM TIMELESS ACBD3 VCL ROCK2 FLNB HYOU1 COPB1 CAST CC2D1B BCAR1 RABL6 TGM2 UBE2O TRNT1 GTF2I MACF1 ROCK1 CCAR2 SZRD1 SNX2 AHNAK2 | 1.85e-08 | 1455 | 198 | 28 | 22863883 |
| Pubmed | RAPGEF6 MYCBP2 CHD4 RREB1 GTF3C4 ALMS1 AHNAK MGA FLNB ZBTB33 CHD8 NCOR1 NCOR2 KMT2D GTF2I | 2.09e-08 | 418 | 198 | 15 | 34709266 | |
| Pubmed | MYCBP2 KIAA0319L NASP CHD4 GTF3C4 GRHPR PKM C1S ACBD3 ALDH5A1 ATRN FLNB ANK2 ANK3 NRCAM COPB1 ADAMTS1 JADE2 ABCC5 MSH3 SLC4A3 RUFY3 FRY UBE2O TMEM168 MACF1 | 2.33e-08 | 1285 | 198 | 26 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES MAP1B MYCBP2 CHD4 HP1BP3 PTPRF SUPT6H AHNAK PKM MGA FLNB VTN HYOU1 COPB1 U2SURP PPP1R9A PELP1 CSTF3 MACF1 CCAR2 SPEN SNX2 FTSJ3 | 2.47e-08 | 1024 | 198 | 23 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ERF CHD4 RREB1 CXXC1 GTF3C4 HP1BP3 PWWP2A SUPT6H AHNAK TAF5 MGA POLB U2SURP MSH3 CREB1 RING1 KANSL3 NCOR1 NCOR2 KMT2D GTF2I PELP1 CTCF ANKRD11 SPEN FTSJ3 | 2.68e-08 | 1294 | 198 | 26 | 30804502 |
| Pubmed | MYCBP2 CHD4 PCDH12 DYSF ALMS1 SUPT6H PKM MYO18B MGA VCL FLNB ANK2 NCOR1 MACF1 PAX7 TNNT3 | 3.15e-08 | 497 | 198 | 16 | 23414517 | |
| Pubmed | ETV3 RREB1 SARS1 SECISBP2 AP1G2 TMEM218 FLNB SLC4A7 ANK2 ADAMTS1 JADE2 AAK1 RUFY3 PYY3 | 3.36e-08 | 371 | 198 | 14 | 15747579 | |
| Pubmed | RAPGEF6 MAP1A RTN1 ADD1 PASK ALMS1 FNIP1 VCL UBE2O MACF1 SNX2 | 3.68e-08 | 209 | 198 | 11 | 36779422 | |
| Pubmed | ERF NASP PKM TIMELESS ROCK2 FLNB AAK1 CHD8 BCAR1 NCOR1 GTF2I AKAP13 SPEN SNX2 TP53BP1 FTSJ3 | 3.71e-08 | 503 | 198 | 16 | 16964243 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | CHD4 RREB1 GTF3C4 ADD1 NFATC3 PKM TAF5 MGA ZBTB33 U2SURP CHD8 CREB1 RING1 GTF2I CTCF CCAR2 TP53BP1 | 4.82e-08 | 583 | 198 | 17 | 29844126 |
| Pubmed | ETV3 CHD4 GTF3C4 TNRC18 MGA ZBTB33 U2SURP CHD8 CREB1 KANSL3 NCOR1 KMT2D | 5.20e-08 | 268 | 198 | 12 | 33640491 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ESS2 MAP1A ALMS1 NFATC3 SUPT6H SECISBP2 SH3RF1 BCAR1 CREB1 RUFY3 KANSL3 NCOR1 NCOR2 MACF1 ROCK1 SPEN TP53BP1 | 5.45e-08 | 588 | 198 | 17 | 38580884 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | CHD4 GTF3C4 AHNAK ZBTB33 ANK2 U2SURP CHD8 GTF2I SMARCA1 CCAR2 TP53BP1 FTSJ3 | 5.87e-08 | 271 | 198 | 12 | 32433965 |
| Pubmed | CHD4 GTF3C4 TNRC18 AHNAK KLHL6 CASC3 FLNB KAT6A CHD8 BCAR1 ANKRD11 MACF1 AHNAK2 | 6.87e-08 | 332 | 198 | 13 | 37433992 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MAP1B GTF3C4 AHNAK TAF5 COPB1 U2SURP CHD8 MSH3 RING1 GTF2I PELP1 CTCF TP53BP1 FTSJ3 | 7.06e-08 | 394 | 198 | 14 | 27248496 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES MAP1B NASP CHD4 KIAA1143 HP1BP3 GRHPR AHNAK PKM ALDH5A1 VCL ROCK2 FLNB ZBTB33 HYOU1 COPB1 AAK1 UPF1 TGM2 NCOR2 UBE2O PELP1 CSTF3 ROCK1 TP53BP1 AHNAK2 | 7.91e-08 | 1367 | 198 | 26 | 32687490 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CHD4 HP1BP3 TAF5 MGA VTN COPB1 POLB CHD8 MSH3 RING1 GTF2I PELP1 CTCF BRD9 SMARCA1 FTSJ3 | 8.20e-08 | 533 | 198 | 16 | 30554943 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 8.27e-08 | 134 | 198 | 9 | 25452129 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES RAPGEF6 MAP1B MYCBP2 ALMS1 NFATC3 AHNAK FNIP1 BOD1L1 CASC3 SLC4A7 SH3RF1 AAK1 STIL BCAR1 ANKRD11 MACF1 AKAP13 SNX2 AHNAK2 | 1.26e-07 | 861 | 198 | 20 | 36931259 |
| Pubmed | HECW1 MAP1A MAP1B MYCBP2 CYTH2 ADGRB2 RTN1 TNRC18 PKM ALDH5A1 WNK2 FLNB SLC4A7 ANK2 ANK3 NRCAM U2SURP AAK1 GRM5 RUFY3 UBE2O MACF1 TP53BP1 | 1.67e-07 | 1139 | 198 | 23 | 36417873 | |
| Pubmed | NES AHNAK PKM FLNB VTN PPP1R9A AAK1 MSH3 CREB1 MACF1 SNX2 TP53BP1 AHNAK2 | 1.74e-07 | 360 | 198 | 13 | 33111431 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP NASP CHD4 SARS1 SUPT6H PKM SGO2 BOD1L1 MYO18B VCL FLNB REXO4 HYOU1 COPB1 U2SURP MSH3 UPF1 UBE2O GTF2I PELP1 SMARCA1 CSTF3 CCAR2 SPEN SNX2 FTSJ3 | 1.77e-07 | 1425 | 198 | 26 | 30948266 |
| Pubmed | Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. | 1.82e-07 | 3 | 198 | 3 | 10209029 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 2.18e-07 | 150 | 198 | 9 | 28242625 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NES RAPGEF6 NASP AHNAK PKM FLNB SLC4A7 ZBTB33 COPB1 GTF2I AHNAK2 | 2.86e-07 | 256 | 198 | 11 | 33397691 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | CLPP NASP CHD4 HP1BP3 SARS1 NKAP FLNB HYOU1 COPB1 U2SURP UPF1 NCOR2 SMARCA1 CCAR2 SPEN SNX2 FTSJ3 | 3.10e-07 | 665 | 198 | 17 | 30457570 |
| Pubmed | ALMS1 SECISBP2 ACBD3 HYOU1 SH3RF1 ANK3 RABL6 UBE2O EFR3B MACF1 AHNAK2 | 3.74e-07 | 263 | 198 | 11 | 34702444 | |
| Pubmed | ESS2 MYCBP2 CHD4 RREB1 KIAA1143 TNRC18 PKM HYOU1 U2SURP CHD8 UPF1 CREB1 KANSL3 NCOR1 NCOR2 KMT2D GTF2I BRD9 CSTF3 CCAR2 SPEN TP53BP1 | 3.88e-07 | 1103 | 198 | 22 | 34189442 | |
| Pubmed | CYTH2 SARS1 AHNAK PKM MYO18B VCL FLNB HYOU1 COPB1 U2SURP CAST NCOR2 UBE2O MACF1 AHNAK2 | 5.37e-07 | 538 | 198 | 15 | 28524877 | |
| Pubmed | MAP1A MAP1B RTN1 ADD1 HP1BP3 SLC12A5 PKM ALDH5A1 ROCK2 ANK2 ANK3 PPP1R9A RUFY3 | 6.26e-07 | 403 | 198 | 13 | 30562941 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MAP1A ADGRB2 AHNAK ANK2 ANK3 NRCAM PPP1R9A AAK1 ARHGEF18 GRM5 MACF1 | 7.19e-07 | 281 | 198 | 11 | 28706196 |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 17185750 | ||
| Pubmed | 7.64e-07 | 128 | 198 | 8 | 23858473 | ||
| Pubmed | 7.69e-07 | 226 | 198 | 10 | 31452512 | ||
| Pubmed | MAP1A MAP1B MYCBP2 LMTK3 RTN1 ADD1 PRRT3 ANK2 NRCAM TNC AAK1 MACF1 | 8.28e-07 | 347 | 198 | 12 | 17114649 | |
| Pubmed | MAP1A CYTH2 ARHGAP31 MGA WNK2 SH3RF1 ANK3 ABI3BP JADE2 CHD8 CREB1 MACF1 AKAP13 WASH2P | 8.84e-07 | 486 | 198 | 14 | 20936779 | |
| Pubmed | CHD4 ADD1 SARS1 SUPT6H PKM ACBD3 FLNB HYOU1 COPB1 UPF1 UBE2O GTF2I PELP1 CSTF3 CCAR2 SNX2 | 8.98e-07 | 638 | 198 | 16 | 33239621 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ADD1 AHNAK VSIG10L PKM ACBD3 VCL FLNB SLC4A7 SH3RF1 ANK3 CAST AAK1 MACF1 ARHGAP18 SNX2 | 9.88e-07 | 565 | 198 | 15 | 25468996 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.10e-06 | 235 | 198 | 10 | 30258100 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NES ESS2 CWC27 NASP CHD4 SUPT6H AHNAK PKM BOD1L1 VCL FLNB REXO4 U2SURP NCOR2 GTF2I PELP1 CTCF CCAR2 TP53BP1 FTSJ3 | 1.10e-06 | 989 | 198 | 20 | 36424410 |
| Pubmed | MYCBP2 PTPRF SECISBP2 MGA ACBD3 VCL FLNB ANK3 NCOR1 TGM2 NCOR2 KMT2D PELP1 MACF1 ROCK1 | 1.72e-06 | 591 | 198 | 15 | 15231748 | |
| Pubmed | Combinatorial roles of the nuclear receptor corepressor in transcription and development. | 1.80e-06 | 5 | 198 | 3 | 11030619 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RAPGEF6 ESS2 ERF ETV3 ADD1 HP1BP3 PASK SARS1 EIF2B2 AP1G2 CASC3 ZC3H12A COPB1 AAK1 UPF1 PPM1B RING1 CRY2 RABL6 CCAR2 | 2.28e-06 | 1038 | 198 | 20 | 26673895 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | LMTK3 SUPT6H EIF2B2 PKM WASHC1 WASHC3 CHD8 UPF1 RABL6 NCOR1 NCOR2 FRY TP53BP1 | 3.83e-06 | 475 | 198 | 13 | 31040226 |
| Pubmed | DYSF SECISBP2 TAF5 FLNB CHD8 NCOR1 NCOR2 FLCN MACF1 AKAP13 SZRD1 | 3.93e-06 | 335 | 198 | 11 | 15741177 | |
| Pubmed | 4.36e-06 | 215 | 198 | 9 | 35973513 | ||
| Pubmed | ESS2 MAP1B MYCBP2 NASP PWWP2A ALMS1 AHNAK SGO2 FLNB POLB RING1 UBE2O ROCK1 SKA1 SPEN | 4.96e-06 | 645 | 198 | 15 | 25281560 | |
| Pubmed | 5.57e-06 | 282 | 198 | 10 | 23667531 | ||
| Pubmed | PALD1 ESS2 MYCBP2 CWC27 KIAA0319L CXXC1 KIAA1143 EIF2B2 SECISBP2 ACBD3 CASC3 SLC4A7 HYOU1 TMEM115 HS1BP3 UPF1 SFT2D3 CCAR2 SNX2 | 5.59e-06 | 1007 | 198 | 19 | 34597346 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.74e-06 | 283 | 198 | 10 | 30585729 | |
| Pubmed | CHD4 GTF3C4 HP1BP3 SUPT6H AHNAK BOD1L1 CHD8 MSH3 UPF1 RING1 KANSL3 NCOR1 NCOR2 TRNT1 GTF2I CTCF BRD9 CSTF3 CCAR2 | 6.16e-06 | 1014 | 198 | 19 | 32416067 | |
| Pubmed | 6.25e-06 | 7 | 198 | 3 | 22629443 | ||
| Pubmed | 6.25e-06 | 7 | 198 | 3 | 11867749 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 6.25e-06 | 7 | 198 | 3 | 23415230 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | CLPP NES MAP1B HP1BP3 AHNAK BOD1L1 ROCK2 FLNB COPB1 POLB AAK1 RUFY3 MACF1 | 6.37e-06 | 498 | 198 | 13 | 36634849 |
| Pubmed | ERICH1 ESS2 ETV3 KIAA1143 PKM VCL CASC3 HYOU1 UPF1 NCOR1 GTF2I PELP1 | 6.65e-06 | 425 | 198 | 12 | 24999758 | |
| Pubmed | ERF MAP1A CHD4 RREB1 PASK ALMS1 NKAP TAF5 MTO1 MGA ZBTB33 ADAMTS1 KAT6A CHD8 NCOR2 CTCF BRD9 SMARCA1 MACF1 FTSJ3 | 6.70e-06 | 1116 | 198 | 20 | 31753913 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | MYCBP2 CHD4 RREB1 PWWP2A TNRC18 COPB1 NCOR1 NCOR2 ANKRD11 CCAR2 | 6.90e-06 | 289 | 198 | 10 | 23752268 |
| Pubmed | 7.01e-06 | 228 | 198 | 9 | 30471916 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 9.31e-06 | 179 | 198 | 8 | 36261009 | |
| Pubmed | 1.07e-05 | 304 | 198 | 10 | 32235678 | ||
| Pubmed | ESS2 MAP1B CXXC1 GTF3C4 TNRC18 MTO1 MGA SH3RF1 WASHC1 KAT6A NCOR1 UBE2O BRD9 ROCK1 AKAP13 | 1.08e-05 | 689 | 198 | 15 | 36543142 | |
| Pubmed | KIFBP PASK ARHGAP31 SUPT6H WNK2 JADE2 AAK1 CHD8 RUFY3 ARHGEF10L KANSL3 UBE2O EFR3B | 1.21e-05 | 529 | 198 | 13 | 14621295 | |
| Pubmed | CHD4 GTF3C4 ITIH2 ADD1 HP1BP3 AHNAK PKM NKAP CASC3 REXO4 VTN ANK2 COPB1 AAK1 UPF1 RING1 KANSL3 TGM2 GTF2I CTCF SMARCA1 FTSJ3 | 1.29e-05 | 1371 | 198 | 22 | 36244648 | |
| Pubmed | 1.38e-05 | 26 | 198 | 4 | 17875933 | ||
| Pubmed | CLPP KIFBP MYCBP2 ADD1 HP1BP3 PASK SARS1 SUPT6H ACBD3 VCL SLC4A7 HYOU1 ANK2 ANK3 UPF1 UBE2O EFR3B ANKRD11 MACF1 AKAP13 SNX2 TP53BP1 FTSJ3 | 1.45e-05 | 1487 | 198 | 23 | 33957083 | |
| Pubmed | An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. | 1.49e-05 | 9 | 198 | 3 | 12007404 | |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 1.51e-05 | 138 | 198 | 7 | 37506885 | |
| Pubmed | 1.51e-05 | 251 | 198 | 9 | 28077445 | ||
| Pubmed | RAPGEF6 NASP BOD1L1 TIMELESS MTO1 MGA KLHL6 FLNB SLC4A7 HYOU1 ANK3 CAST ARHGEF18 WASHC3 TRNT1 MACF1 ROCK1 SZRD1 TP53BP1 | 1.57e-05 | 1084 | 198 | 19 | 11544199 | |
| Pubmed | GTF3C4 ALMS1 SUPT6H AHNAK BOD1L1 CHD8 KMT2D PELP1 SMARCA1 CCAR2 SPEN TP53BP1 | 1.77e-05 | 469 | 198 | 12 | 27634302 | |
| Pubmed | 1.82e-05 | 257 | 198 | 9 | 16335952 | ||
| Interaction | H3C1 interactions | NASP CHD4 KIAA1143 GTF3C4 ITIH2 HP1BP3 TNRC18 SARS1 AHNAK TAF5 MGA DNAH8 ROCK2 REXO4 ANK2 ANK3 U2SURP KAT6A CAST CHD8 MSH3 CREB1 NCOR1 KMT2D PIEZO2 PELP1 CTCF SMARCA1 CSTF3 SPEN TP53BP1 FTSJ3 | 2.30e-10 | 901 | 197 | 32 | int:H3C1 |
| Interaction | H3C3 interactions | ESS2 CWC27 NASP CHD4 RREB1 KIAA1143 GTF3C4 HP1BP3 PWWP2A SUPT6H SGO2 BOD1L1 TIMELESS MGA REXO4 CHD8 MSH3 RING1 UBE2O GTF2I BRD9 SMARCA1 SPEN | 6.58e-10 | 495 | 197 | 23 | int:H3C3 |
| Interaction | NAA40 interactions | PALD1 RAPGEF6 MAP1A MAP1B NASP CHD4 RTN1 KIAA1143 GTF3C4 ADD1 HP1BP3 ALMS1 AHNAK PKM BOD1L1 ACBD3 VCL ZBTB33 ANK2 COPB1 U2SURP CAST AAK1 UPF1 UBE2O GTF2I CTCF MACF1 TP53BP1 AHNAK2 FTSJ3 | 6.86e-09 | 978 | 197 | 31 | int:NAA40 |
| Interaction | H3-3A interactions | ERICH1 ESS2 CWC27 NASP CHD4 RREB1 KIAA1143 GTF3C4 HP1BP3 PWWP2A BOD1L1 TIMELESS MGA REXO4 FOSB KAT6A CHD8 MSH3 RING1 KMT2D GTF2I PELP1 BRD9 SMARCA1 SPEN SNX2 | 2.13e-08 | 749 | 197 | 26 | int:H3-3A |
| Interaction | TERF2IP interactions | ERICH1 ESS2 CWC27 NASP RREB1 KIAA1143 GTF3C4 HP1BP3 SUPT6H BOD1L1 MGA U2SURP CHD8 MSH3 KANSL3 NCOR1 NCOR2 GTF2I CTCF SMARCA1 ANKRD11 SPEN | 2.57e-08 | 552 | 197 | 22 | int:TERF2IP |
| Interaction | GUSBP5 interactions | 4.89e-08 | 75 | 197 | 9 | int:GUSBP5 | |
| Interaction | NUP43 interactions | ERF HP1BP3 SUPT6H BOD1L1 TIMELESS NKAP MGA REXO4 KTI12 CHD8 KANSL3 NCOR1 NCOR2 KMT2D GTF2I PELP1 CTCF SMARCA1 ANKRD11 CCAR2 SPEN AHNAK2 FTSJ3 | 5.22e-08 | 625 | 197 | 23 | int:NUP43 |
| Interaction | H2BC8 interactions | ESS2 CWC27 CHD4 RREB1 CXXC1 KIAA1143 GTF3C4 HP1BP3 PWWP2A SGO2 MGA REXO4 POLB CHD8 MSH3 RING1 TGM2 UBE2O GTF2I CTCF SMARCA1 SPEN | 5.44e-08 | 576 | 197 | 22 | int:H2BC8 |
| Interaction | TOP3B interactions | PALD1 RAPGEF6 MYCBP2 SPEG KIAA0319L ADGRB2 DYSF SLC38A10 TNRC18 PTPRF AHNAK SECISBP2 AP1G2 WNK2 HYOU1 SH3RF1 PPP1R9A KAT6A KTI12 CHD8 MSH3 UPF1 ARHGEF10L KANSL3 RABL6 NCOR1 NCOR2 KMT2D GTF2I PELP1 ANKRD11 FLCN AKAP13 SPEN TP53BP1 AHNAK2 | 2.66e-07 | 1470 | 197 | 36 | int:TOP3B |
| Interaction | SIRT7 interactions | NES MAP1B MYCBP2 CHD4 HP1BP3 SUPT6H AHNAK VCL FLNB REXO4 HYOU1 COPB1 U2SURP CHD8 UPF1 UBE2O GTF2I PELP1 CTCF MACF1 CCAR2 SPEN TP53BP1 FTSJ3 | 2.99e-07 | 744 | 197 | 24 | int:SIRT7 |
| Interaction | YAP1 interactions | RAPGEF6 ESS2 HECW1 CWC27 NASP CHD4 GTF3C4 ADD1 TNRC18 AHNAK PKM BOD1L1 TAF5 MGA VCL FLNB ZBTB33 HYOU1 ANK3 CAST CHD8 UPF1 CREB1 NCOR1 TGM2 UBE2O KMT2D GTF2I SPEN SNX2 | 3.03e-07 | 1095 | 197 | 30 | int:YAP1 |
| Interaction | SUMO2 interactions | CHD4 LMTK3 RREB1 GTF3C4 HP1BP3 SARS1 AHNAK PKM BOD1L1 FLNB ZBTB33 CAST CHD8 MSH3 UPF1 NCOR1 GTF2I PELP1 CCAR2 TP53BP1 AHNAK2 | 3.68e-07 | 591 | 197 | 21 | int:SUMO2 |
| Interaction | NFIX interactions | RREB1 CXXC1 TAF5 MGA VCL CREB1 RING1 KANSL3 NCOR1 NCOR2 KMT2D PAX7 SPEN | 3.87e-07 | 227 | 197 | 13 | int:NFIX |
| Interaction | GSK3A interactions | RAPGEF6 MAP1A TTC16 LRRC37A2 DRC1 RTN1 ADD1 PASK TNRC18 ALMS1 FNIP1 VCL U2SURP BCAR1 CREB1 UBE2O MACF1 SNX2 | 7.55e-07 | 464 | 197 | 18 | int:GSK3A |
| Interaction | KCNA3 interactions | CHL1 PALD1 MAP1B ADD1 AHNAK PKM BOD1L1 VCL ROCK2 FLNB ZBTB33 HYOU1 SH3RF1 ANK2 ANK3 COPB1 AAK1 ABCC5 CC2D1B UPF1 RABL6 EFR3B MACF1 ROCK1 SPEN | 1.42e-06 | 871 | 197 | 25 | int:KCNA3 |
| Interaction | DCAF15 interactions | MAP1A MAP1B MGA VCL ROCK2 FLNB CAST AAK1 STIL RUFY3 CRY2 RABL6 TGM2 | 1.44e-06 | 255 | 197 | 13 | int:DCAF15 |
| Interaction | SMC5 interactions | MAP1B CHD4 RREB1 HP1BP3 AHNAK SGO2 BOD1L1 TIMELESS MGA REXO4 ZBTB33 U2SURP CAST CHD8 BCAR1 CREB1 NCOR1 NCOR2 GTF2I PELP1 CTCF BRD9 ANKRD11 CSTF3 SPEN TP53BP1 FTSJ3 | 1.67e-06 | 1000 | 197 | 27 | int:SMC5 |
| Interaction | PYHIN1 interactions | MAP1B CHD4 RREB1 GTF3C4 HP1BP3 SUPT6H MGA ADAMTS1 U2SURP UPF1 PELP1 CTCF SMARCA1 CCAR2 SPEN | 2.57e-06 | 358 | 197 | 15 | int:PYHIN1 |
| Interaction | BAG2 interactions | PALD1 RAPGEF6 ESS2 MAP1B CHD4 RREB1 CXXC1 SUPT6H AHNAK BOD1L1 MTO1 AAK1 STIL CRY2 NCOR1 CSTF3 CCAR2 ARHGAP18 SKA1 SPEN | 3.27e-06 | 622 | 197 | 20 | int:BAG2 |
| Interaction | CBX3 interactions | ERICH1 ESS2 CWC27 CHD4 RREB1 KIAA1143 GTF3C4 HP1BP3 MGA REXO4 HTR2C CHD8 RING1 NCOR1 UBE2O GTF2I SMARCA1 MACF1 SPEN TP53BP1 | 5.74e-06 | 646 | 197 | 20 | int:CBX3 |
| Interaction | ASF1A interactions | ESS2 NASP RREB1 SARS1 MGA COPB1 CHD8 NCOR1 NCOR2 KMT2D CCAR2 SPEN | 6.55e-06 | 249 | 197 | 12 | int:ASF1A |
| Interaction | CDH1 interactions | CHD4 ADD1 PTPRF AHNAK VSIG10L PKM ACBD3 VCL ROCK2 FLNB SLC4A7 SH3RF1 ANK3 CAST AAK1 UPF1 BCAR1 TGM2 MACF1 ROCK1 ARHGAP18 SNX2 | 6.61e-06 | 768 | 197 | 22 | int:CDH1 |
| Interaction | SETD1A interactions | CHD4 CXXC1 AHNAK BOD1L1 CHD8 KANSL3 KMT2D CTCF SMARCA1 TP53BP1 | 6.94e-06 | 170 | 197 | 10 | int:SETD1A |
| Interaction | FOXQ1 interactions | 1.05e-05 | 141 | 197 | 9 | int:FOXQ1 | |
| Interaction | H2AC4 interactions | CHD4 CXXC1 GTF3C4 HP1BP3 ALMS1 SUPT6H TIMELESS COPB1 CHD8 BCAR1 RING1 KMT2D GTF2I PELP1 CTCF TP53BP1 FTSJ3 | 1.05e-05 | 506 | 197 | 17 | int:H2AC4 |
| Interaction | LHX2 interactions | 1.33e-05 | 183 | 197 | 10 | int:LHX2 | |
| Interaction | NR2C2 interactions | ESS2 ETV3 NASP CHD4 RREB1 ADD1 HP1BP3 AHNAK PKM NKAP TAF5 CASC3 HYOU1 SH3RF1 COPB1 U2SURP CHD8 UPF1 KANSL3 RABL6 NCOR1 TGM2 TRNT1 GTF2I PRG2 BRD9 CCAR2 PAX7 SNX2 TP53BP1 FTSJ3 | 1.63e-05 | 1403 | 197 | 31 | int:NR2C2 |
| Interaction | CENPA interactions | KIFBP RREB1 GTF3C4 HP1BP3 SGO2 REXO4 KAT6A MSH3 RING1 GTF2I BRD9 SMARCA1 ANKRD11 FTSJ3 | 2.17e-05 | 377 | 197 | 14 | int:CENPA |
| Interaction | H2AX interactions | CHD4 CXXC1 TNRC18 MAGEB10 SUPT6H PKM TIMELESS REXO4 HYOU1 CHD8 UPF1 BCAR1 RING1 UBE2O PELP1 CTCF SMARCA1 TP53BP1 | 2.24e-05 | 593 | 197 | 18 | int:H2AX |
| Interaction | ZYX interactions | RTN1 ALMS1 ARHGAP31 VCL KLHL6 SH3RF1 ANK2 AAK1 BCAR1 MACF1 AKAP13 SKA1 AHNAK2 | 2.26e-05 | 329 | 197 | 13 | int:ZYX |
| Interaction | ADARB1 interactions | CHD4 GTF3C4 HP1BP3 AHNAK REXO4 ZBTB33 ANK2 U2SURP CHD8 UPF1 GTF2I CTCF SMARCA1 CCAR2 TP53BP1 FTSJ3 | 2.65e-05 | 489 | 197 | 16 | int:ADARB1 |
| Interaction | POLR1G interactions | KIFBP CWC27 RREB1 KIAA1143 GTF3C4 SUPT6H SGO2 MGA REXO4 KAT6A CHD8 PELP1 CTCF SMARCA1 ANKRD11 FTSJ3 | 2.65e-05 | 489 | 197 | 16 | int:POLR1G |
| Interaction | KLF15 interactions | ERF HP1BP3 TAF5 MGA RING1 NCOR1 NCOR2 KMT2D GTF2I CTCF CCAR2 FTSJ3 | 2.99e-05 | 290 | 197 | 12 | int:KLF15 |
| Interaction | RCOR1 interactions | RAPGEF6 MYCBP2 CHD4 RREB1 ALMS1 AHNAK MGA ZBTB33 CHD8 NCOR1 NCOR2 KMT2D GTF2I PAX7 SPEN TP53BP1 | 3.00e-05 | 494 | 197 | 16 | int:RCOR1 |
| Interaction | SHANK3 interactions | NES HECW1 MAP1A MAP1B LMTK3 SLC12A5 PKM ROCK2 HYOU1 ANK2 ANK3 NRCAM PPP1R9A AAK1 GRM5 MACF1 | 3.15e-05 | 496 | 197 | 16 | int:SHANK3 |
| Interaction | FEV interactions | 3.24e-05 | 203 | 197 | 10 | int:FEV | |
| Interaction | MAD2L1 interactions | ESS2 CHD4 CXXC1 SGO2 BOD1L1 TAF5 MGA PPP1R9A KAT6A CHD8 MACF1 | 3.98e-05 | 252 | 197 | 11 | int:MAD2L1 |
| Interaction | TBL1Y interactions | 4.23e-05 | 40 | 197 | 5 | int:TBL1Y | |
| Interaction | AGR2 interactions | MYCBP2 CHD4 GTF3C4 HP1BP3 GJA8 GRHPR AHNAK PKM VCL FLNB HYOU1 ANK3 COPB1 CHD8 UPF1 CREB1 TGM2 GOLPH3L ANKRD11 MACF1 AKAP13 ARHGAP18 AHNAK2 | 4.46e-05 | 934 | 197 | 23 | int:AGR2 |
| Interaction | PPP1R9B interactions | MAP1A MAP1B MYCBP2 LMTK3 RTN1 ADD1 HP1BP3 SLC12A5 PKM BOD1L1 ALDH5A1 ROCK2 ANK2 ANK3 PPP1R9A UPF1 RUFY3 RING1 | 4.54e-05 | 626 | 197 | 18 | int:PPP1R9B |
| Interaction | MYB interactions | 4.99e-05 | 133 | 197 | 8 | int:MYB | |
| Interaction | SYNGAP1 interactions | MAP1A MAP1B MYCBP2 CYTH2 ADGRB2 ALDH5A1 ANK2 AAK1 GRM5 RUFY3 AKAP13 TP53BP1 | 5.20e-05 | 307 | 197 | 12 | int:SYNGAP1 |
| Interaction | ASH2L interactions | CXXC1 BOD1L1 MGA JADE2 CHD8 KANSL3 KMT2D PELP1 CCAR2 PAX7 TP53BP1 | 6.27e-05 | 265 | 197 | 11 | int:ASH2L |
| Interaction | CSNK2A1 interactions | RGS19 CHD4 HP1BP3 SUPT6H NKAP MGA KLHL6 VTN JADE2 KAT6A UPF1 CREB1 RING1 CRY2 NCOR1 UBE2O BRD9 ANKRD11 MACF1 PAX7 ARHGAP18 VSX2 FTSJ3 | 6.36e-05 | 956 | 197 | 23 | int:CSNK2A1 |
| Interaction | WDR5 interactions | CHD4 CXXC1 ITIH2 ADD1 PASK SARS1 PKM BOD1L1 MGA FLNB HYOU1 COPB1 KAT6A CHD8 UPF1 RING1 KANSL3 UBE2O KMT2D GTF2I PELP1 CTCF BRD9 MACF1 PAX7 | 7.61e-05 | 1101 | 197 | 25 | int:WDR5 |
| Interaction | FOXK2 interactions | MAP1B CHD4 KAT6A BCAR1 KANSL3 NCOR1 NCOR2 KMT2D SMARCA1 TP53BP1 | 7.71e-05 | 225 | 197 | 10 | int:FOXK2 |
| Interaction | YWHAH interactions | NES RAPGEF6 MYCBP2 SPEG CYTH2 ALMS1 NFATC3 AHNAK FNIP1 BOD1L1 WNK2 VCL CASC3 SLC4A7 SH3RF1 AAK1 STIL BCAR1 ANKRD11 FLCN MACF1 CCAR2 AKAP13 SNX2 AHNAK2 | 7.72e-05 | 1102 | 197 | 25 | int:YWHAH |
| Interaction | FMR1 interactions | MAP1B MYCBP2 CHD4 LMTK3 AHNAK SECISBP2 ROCK2 CASC3 KAT6A ARHGEF18 UPF1 NCOR1 NCOR2 MACF1 CCAR2 TP53BP1 | 7.88e-05 | 536 | 197 | 16 | int:FMR1 |
| Interaction | GOLGA4 interactions | TIMELESS COPB1 WASHC3 KTI12 BCAR1 TGM2 TRNT1 CTCF MACF1 CCAR2 | 7.99e-05 | 226 | 197 | 10 | int:GOLGA4 |
| Interaction | ATXN1 interactions | CLPP NASP CHD4 HP1BP3 SARS1 NKAP WNK2 FLNB HYOU1 COPB1 U2SURP KAT6A UPF1 CRY2 NCOR1 NCOR2 FAM153B PELP1 SMARCA1 CCAR2 PAX7 SPEN SNX2 FTSJ3 | 8.23e-05 | 1039 | 197 | 24 | int:ATXN1 |
| Interaction | SRPK2 interactions | MYCBP2 EPB41L4A GTF3C4 HP1BP3 ALMS1 SUPT6H NKAP MYO18B REXO4 ANK3 POLB U2SURP KAT6A PELP1 CTCF MACF1 AKAP13 SPEN FTSJ3 | 8.25e-05 | 717 | 197 | 19 | int:SRPK2 |
| Interaction | KLF3 interactions | 8.60e-05 | 228 | 197 | 10 | int:KLF3 | |
| Interaction | NFIA interactions | 1.00e-04 | 188 | 197 | 9 | int:NFIA | |
| Interaction | EP300 interactions | NASP CHD4 CXXC1 SUPT6H PKM ROCK2 CASC3 ZC3H12A ZBTB33 COPB1 POLB FOSB U2SURP KAT6A UPF1 CREB1 RING1 RABL6 NCOR1 NCOR2 KMT2D GTF2I PELP1 CTCF CSTF3 ROCK1 CCAR2 PAX7 TP53BP1 | 1.01e-04 | 1401 | 197 | 29 | int:EP300 |
| Interaction | AIM2 interactions | 1.04e-04 | 110 | 197 | 7 | int:AIM2 | |
| Interaction | MEX3A interactions | CHD4 GTF3C4 TNRC18 AHNAK KLHL6 CASC3 FLNB KAT6A CHD8 BCAR1 ANKRD11 MACF1 AHNAK2 | 1.09e-04 | 384 | 197 | 13 | int:MEX3A |
| Interaction | CIC interactions | CHD4 RREB1 GTF3C4 ADD1 NFATC3 PKM TAF5 MGA ZBTB33 U2SURP CHD8 CREB1 RING1 GTF2I CTCF CCAR2 PAX7 TP53BP1 | 1.14e-04 | 673 | 197 | 18 | int:CIC |
| Interaction | PML interactions | ESS2 MAP1A MAP1B CHD4 GTF3C4 HP1BP3 PTPRF AHNAK PKM REXO4 ZBTB33 KAT6A AAK1 CHD8 UPF1 KANSL3 NCOR1 NCOR2 GTF2I PELP1 TP53BP1 AHNAK2 | 1.24e-04 | 933 | 197 | 22 | int:PML |
| Interaction | FAM153CP interactions | 1.43e-04 | 11 | 197 | 3 | int:FAM153CP | |
| Interaction | TRIM37 interactions | MAP1A ALMS1 ARHGAP31 AHNAK PKM MGA FLNB COPB1 U2SURP ARHGEF18 STIL NCOR1 NCOR2 KMT2D ANKRD11 CCAR2 SPEN | 1.59e-04 | 630 | 197 | 17 | int:TRIM37 |
| Interaction | ARL16 interactions | 1.63e-04 | 83 | 197 | 6 | int:ARL16 | |
| Interaction | FGFR1 interactions | EPB41L4A RTN1 GJA8 PKM ACBD3 VCL ROCK2 HYOU1 ANK2 ANK3 COPB1 BCAR1 PPM1B EFR3B ROCK1 SNX2 ARMH4 | 1.65e-04 | 632 | 197 | 17 | int:FGFR1 |
| Interaction | PRNP interactions | ESS2 MAP1B CXXC1 RTN1 GTF3C4 TNRC18 MTO1 MGA ALDH5A1 SH3RF1 ANK2 TNC WASHC1 KAT6A CAST AAK1 GRM5 PPM1B RABL6 NCOR1 UBE2O BRD9 MACF1 ROCK1 AKAP13 | 1.68e-04 | 1158 | 197 | 25 | int:PRNP |
| Interaction | CHL1 interactions | 1.90e-04 | 12 | 197 | 3 | int:CHL1 | |
| Interaction | ARF6 interactions | PALD1 CYTH2 KIAA0319L ADD1 PTPRF AHNAK ACBD3 ROCK2 SLC4A7 ANK3 COPB1 ABCC5 LIPE EFR3B ROCK1 SNX2 | 2.10e-04 | 584 | 197 | 16 | int:ARF6 |
| Interaction | MECOM interactions | MAP1B CHD4 HP1BP3 PKM COPB1 PPP1R9A MSH3 UPF1 GTF2I ANKRD11 TP53BP1 FTSJ3 | 2.20e-04 | 358 | 197 | 12 | int:MECOM |
| Interaction | KCTD13 interactions | NES MAP1A MAP1B CYTH2 RTN1 ADD1 HP1BP3 SLC12A5 SARS1 PKM WNK2 VCL ROCK2 FLNB HYOU1 ANK2 ANK3 NRCAM COPB1 TNC PPP1R9A AAK1 UPF1 GRM5 RUFY3 UBE2O MACF1 SNX2 | 2.22e-04 | 1394 | 197 | 28 | int:KCTD13 |
| Interaction | NHLH1 interactions | 2.25e-04 | 88 | 197 | 6 | int:NHLH1 | |
| Interaction | NFIC interactions | 2.31e-04 | 210 | 197 | 9 | int:NFIC | |
| Interaction | AGAP2 interactions | 2.31e-04 | 210 | 197 | 9 | int:AGAP2 | |
| Interaction | CSNK2A2 interactions | ESS2 RGS19 CHD4 GTF3C4 EIF2B2 SGO2 NKAP MGA KLHL6 JADE2 KAT6A RING1 TGM2 UBE2O PELP1 VSX2 TP53BP1 AHNAK2 | 2.52e-04 | 718 | 197 | 18 | int:CSNK2A2 |
| Interaction | HMGA1 interactions | CWC27 CHD4 HP1BP3 PWWP2A TNRC18 POLB KAT6A CREB1 NCOR2 UBE2O GTF2I SMARCA1 SPEN | 2.57e-04 | 419 | 197 | 13 | int:HMGA1 |
| Interaction | ITGB3 interactions | 2.75e-04 | 170 | 197 | 8 | int:ITGB3 | |
| Interaction | WWTR1 interactions | RAPGEF6 MAP1B MYCBP2 ALMS1 ZBTB33 ANK3 CHD8 NCOR1 UBE2O KMT2D GTF2I SNX2 TP53BP1 | 2.75e-04 | 422 | 197 | 13 | int:WWTR1 |
| Interaction | PCGF6 interactions | 2.86e-04 | 171 | 197 | 8 | int:PCGF6 | |
| Interaction | HAT1 interactions | 2.94e-04 | 217 | 197 | 9 | int:HAT1 | |
| Interaction | KLF16 interactions | ESS2 NASP RREB1 HP1BP3 TAF5 MGA ZBTB33 KANSL3 KMT2D GTF2I CTCF CCAR2 FTSJ3 | 2.95e-04 | 425 | 197 | 13 | int:KLF16 |
| Interaction | SMG7 interactions | ESS2 SECISBP2 CHD8 UPF1 STIL RING1 NCOR1 NCOR2 UBE2O KMT2D CSTF3 | 3.17e-04 | 319 | 197 | 11 | int:SMG7 |
| Interaction | RNF2 interactions | CHD4 DYSF CXXC1 GTF3C4 HP1BP3 SGO2 MGA FLNB ZBTB33 HYOU1 ANK3 COPB1 WASHC1 UPF1 RING1 KMT2D GTF2I PELP1 PAX7 FTSJ3 | 3.33e-04 | 866 | 197 | 20 | int:RNF2 |
| Interaction | CHAF1A interactions | NASP CHD4 RTN1 PWWP2A TIMELESS KAT6A TIGD6 GTF2I PELP1 SMARCA1 TP53BP1 | 3.43e-04 | 322 | 197 | 11 | int:CHAF1A |
| Interaction | STIP1 interactions | NASP CHD4 ADD1 SARS1 SUPT6H AHNAK PKM FNIP1 ACBD3 FLNB HYOU1 COPB1 UPF1 STIL ARHGEF10L UBE2O GTF2I PELP1 CSTF3 FLCN CCAR2 SNX2 | 3.54e-04 | 1006 | 197 | 22 | int:STIP1 |
| Interaction | KDM1A interactions | KIFBP RAPGEF6 MYCBP2 CHD4 RREB1 GTF3C4 ALMS1 AHNAK AP1G2 MTO1 MGA FLNB ZBTB33 WASHC3 CHD8 NCOR1 NCOR2 KMT2D GTF2I PELP1 TP53BP1 | 3.72e-04 | 941 | 197 | 21 | int:KDM1A |
| Interaction | KPNA4 interactions | 3.84e-04 | 225 | 197 | 9 | int:KPNA4 | |
| Interaction | H2AB3 interactions | 3.87e-04 | 136 | 197 | 7 | int:H2AB3 | |
| Interaction | TNIK interactions | NES MYCBP2 TAF5 MGA ANK2 ANK3 CHD8 GRM5 NCOR2 MACF1 CCAR2 TP53BP1 | 3.87e-04 | 381 | 197 | 12 | int:TNIK |
| Interaction | HNF4A interactions | 3.91e-04 | 275 | 197 | 10 | int:HNF4A | |
| Interaction | EED interactions | CHL1 MAP1B MYCBP2 CHD4 GTF3C4 HP1BP3 PWWP2A SUPT6H PKM MGA FLNB VTN HYOU1 COPB1 MSH3 HS1BP3 UPF1 RING1 NCOR1 GTF2I CTCF SMARCA1 MACF1 CCAR2 SPEN SNX2 TP53BP1 FTSJ3 | 3.97e-04 | 1445 | 197 | 28 | int:EED |
| Interaction | ANK2 interactions | 4.04e-04 | 98 | 197 | 6 | int:ANK2 | |
| Interaction | KLF8 interactions | RREB1 TAF5 MGA RING1 KANSL3 NCOR2 KMT2D GTF2I CTCF CCAR2 SPEN | 4.11e-04 | 329 | 197 | 11 | int:KLF8 |
| Interaction | CSNK2B interactions | ERICH1 CHD4 ADD1 NKAP U2SURP KAT6A CHD8 UPF1 CREB1 RING1 CRY2 UBE2O CTCF ANKRD11 SNX2 FTSJ3 | 4.45e-04 | 625 | 197 | 16 | int:CSNK2B |
| Interaction | PHLPP1 interactions | NES RAPGEF6 NASP AHNAK PKM FLNB SLC4A7 ZBTB33 COPB1 GTF2I AHNAK2 | 4.55e-04 | 333 | 197 | 11 | int:PHLPP1 |
| Interaction | RYBP interactions | 4.79e-04 | 232 | 197 | 9 | int:RYBP | |
| Interaction | BUB3 interactions | 4.79e-04 | 232 | 197 | 9 | int:BUB3 | |
| Interaction | H3-4 interactions | NASP CHD4 RREB1 GTF3C4 AHNAK TAF5 MGA JADE2 KAT6A CREB1 RING1 TGM2 TNNT3 | 4.86e-04 | 448 | 197 | 13 | int:H3-4 |
| Interaction | PARP1 interactions | KIFBP MYCBP2 CWC27 CHD4 RREB1 HP1BP3 SUPT6H EIF2B2 SGO2 TIMELESS MGA REXO4 HYOU1 POLB U2SURP MSH3 PPM1B RABL6 UBE2O CTCF SMARCA1 ROCK1 CCAR2 SNX2 TP53BP1 FTSJ3 | 4.87e-04 | 1316 | 197 | 26 | int:PARP1 |
| Interaction | DLG4 interactions | MAP1A CYTH2 ADGRB2 GRIN3B ROCK2 SLC4A7 HTR2C ANK2 ANK3 NRCAM RING1 TRNT1 MACF1 | 4.96e-04 | 449 | 197 | 13 | int:DLG4 |
| Interaction | CEBPA interactions | ESS2 MYCBP2 CHD4 RREB1 KIAA1143 HP1BP3 TNRC18 PKM HYOU1 U2SURP CHD8 UPF1 CREB1 KANSL3 NCOR1 NCOR2 KMT2D GTF2I BRD9 CSTF3 MACF1 CCAR2 SPEN TP53BP1 FTSJ3 | 4.97e-04 | 1245 | 197 | 25 | int:CEBPA |
| Interaction | NOL9 interactions | 5.01e-04 | 142 | 197 | 7 | int:NOL9 | |
| Interaction | ZBTB2 interactions | KIFBP CHD4 ROCK2 COPB1 KAT6A CREB1 UBE2O PELP1 CTCF SMARCA1 ROCK1 ARHGAP18 TP53BP1 | 5.06e-04 | 450 | 197 | 13 | int:ZBTB2 |
| Interaction | IFITM3 interactions | KIAA0319L RTN1 ACBD3 ROCK2 COPB1 ADAMTS1 WASHC3 MSH3 SFT2D3 BCAR1 RUFY3 ROCK1 SNX2 AHNAK2 | 5.45e-04 | 513 | 197 | 14 | int:IFITM3 |
| GeneFamily | Fibronectin type III domain containing | 1.91e-04 | 160 | 134 | 7 | 555 | |
| GeneFamily | PHD finger proteins | 5.51e-04 | 90 | 134 | 5 | 88 | |
| GeneFamily | Ferlin family | 8.02e-04 | 6 | 134 | 2 | 828 | |
| GeneFamily | WASH complex | 8.02e-04 | 6 | 134 | 2 | 1331 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.13e-04 | 25 | 134 | 3 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B MYCBP2 NFATC3 ACBD3 VCL ROCK2 ATRN FLNB SLC4A7 U2SURP KAT6A MSH3 STIL CREB1 PPM1B NCOR2 CTCF SMARCA1 MACF1 ROCK1 AKAP13 SPEN SNX2 TP53BP1 | 2.69e-08 | 856 | 195 | 24 | M4500 |
| Coexpression | GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN | 2.49e-06 | 198 | 195 | 10 | M5571 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | ESS2 RGS19 NASP CHD4 PTPRF TIMELESS MGA CASC3 SH3RF1 POLB MSH3 SLC4A3 RUFY3 TMEM168 PELP1 CSTF3 VSX2 SKA1 SPEN | 5.96e-06 | 776 | 195 | 19 | M1107 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | ESS2 RGS19 NASP CHD4 PTPRF TIMELESS MGA CASC3 SH3RF1 POLB MSH3 SLC4A3 RUFY3 TMEM168 PELP1 CSTF3 VSX2 SKA1 SPEN | 8.25e-06 | 794 | 195 | 19 | MM982 |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | CHL1 KIFBP KIAA0319L ADGRB2 NASP KIAA1143 HP1BP3 PTPRF TMEM218 BOD1L1 TAF5 SLC4A7 HYOU1 TMEM115 ARHGEF10L MACF1 SPEN SLC37A4 SZRD1 | 1.04e-05 | 807 | 195 | 19 | M14594 |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | ERF KIAA0319L ADGRB2 EPB41L4A RTN1 HP1BP3 SUPT6H TNC ABCC5 SZRD1 | 1.46e-05 | 242 | 195 | 10 | M12816 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RAPGEF6 SPN MYCBP2 RGS19 ADD1 NFATC3 AHNAK SECISBP2 BOD1L1 SLC4A7 COPB1 JADE2 FOSB U2SURP KAT6A AAK1 CREB1 PPM1B NCOR1 KMT2D CTCF ANKRD11 MACF1 ROCK1 AKAP13 LSP1 SPEN | 1.75e-05 | 1492 | 195 | 27 | M40023 |
| Coexpression | GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP | 1.93e-05 | 199 | 195 | 9 | M3754 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 1.93e-05 | 199 | 195 | 9 | M9964 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.93e-05 | 199 | 195 | 9 | M5893 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.93e-05 | 199 | 195 | 9 | M5251 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 2.01e-05 | 200 | 195 | 9 | M4538 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 2.01e-05 | 200 | 195 | 9 | M5089 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP | 2.01e-05 | 200 | 195 | 9 | M5093 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.18e-05 | 212 | 195 | 9 | M39221 | |
| Coexpression | SENESE_HDAC1_TARGETS_DN | CYTH2 ADGRB2 SLC38A10 AHNAK AP1G2 ALDH5A1 ROCK2 BCAR1 SMARCA1 LSP1 | 3.38e-05 | 267 | 195 | 10 | M6100 |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 4.21e-05 | 85 | 195 | 6 | M41085 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_DN | 4.68e-05 | 10 | 195 | 3 | M9172 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ADGRB2 NASP PASK ALMS1 PRRT3 PKM SGO2 WNK2 NRCAM MSH3 STIL RUFY3 SMARCA1 CSTF3 SKA1 TP53BP1 | 5.35e-05 | 680 | 195 | 16 | MM456 |
| Coexpression | LIAO_METASTASIS | ESS2 MAP1B VSIG10L PKM REXO4 HYOU1 NRCAM PPP1R9A BCAS4 RABL6 UBE2O BRD9 FLCN SZRD1 | 5.71e-05 | 540 | 195 | 14 | M13809 |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP | 6.38e-05 | 180 | 195 | 8 | M357 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 7.16e-05 | 183 | 195 | 8 | M8189 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | MAP1B VCL ROCK2 FLNB SLC4A7 ADAMTS1 TGM2 PIEZO2 ANKRD11 MACF1 | 7.79e-05 | 295 | 195 | 10 | M39121 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 ABCA3 RAPGEF6 MAP1B MYCBP2 SPEG RTN1 SLC12A5 BOD1L1 ANK2 ANK3 PPP1R9A ABCC5 GRM5 SLC4A3 RUFY3 FRY PIEZO2 ZFHX2 AHNAK2 ARMH4 | 8.29e-05 | 1106 | 195 | 21 | M39071 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | MAP1B RTN1 SLC12A5 PTPRF GRHPR BOD1L1 TIMELESS MMP10 CNGB1 VTN HYOU1 HTR2C ANK3 NRCAM TNC POLB PPP1R9A SLC13A3 BCAR1 GRM5 SLC4A3 PRG2 SLC37A4 | 8.69e-05 | 1281 | 195 | 23 | M1884 |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | NES MAP1A MAP1B IRAG1 ADD1 SARS1 AHNAK PKM C1S ABI3BP WASHC3 TGM2 FRY ARHGAP18 | 9.57e-05 | 567 | 195 | 14 | M2129 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 1.00e-04 | 192 | 195 | 8 | M8272 | |
| Coexpression | GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP | 1.15e-04 | 196 | 195 | 8 | M7389 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 1.24e-04 | 198 | 195 | 8 | M3195 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.28e-04 | 199 | 195 | 8 | M5201 | |
| Coexpression | GSE11924_TH1_VS_TH2_CD4_TCELL_DN | 1.28e-04 | 199 | 195 | 8 | M3160 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 1.28e-04 | 199 | 195 | 8 | M4350 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 1.33e-04 | 200 | 195 | 8 | M4590 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NKCELL_UP | 1.33e-04 | 200 | 195 | 8 | M4822 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN | 1.33e-04 | 200 | 195 | 8 | M3725 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP | 1.33e-04 | 200 | 195 | 8 | M3774 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | MAP1B MYCBP2 LMTK3 RTN1 SLC12A5 CNGB1 ANK2 GRM5 SLC4A3 RUFY3 FRY ZFHX2 | 1.50e-04 | 450 | 195 | 12 | M39072 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | CYTH2 KIAA0319L ETV3 LMTK3 DYSF CXXC1 FNIP1 AP1G2 ROCK2 ZC3H12A WASHC1 AAK1 CREB1 BRD9 ANKRD11 AKAP13 ARHGAP27 SPEN | 1.55e-04 | 905 | 195 | 18 | M40865 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | ESS2 KIAA0319L RREB1 EPB41L4A TNRC18 SUPT6H BOD1L1 ROCK2 SH3RF1 KAT6A ARHGEF10L RING1 RABL6 ANKRD11 TNNT3 SKA1 | 1.56e-04 | 746 | 195 | 16 | M40863 |
| Coexpression | HAN_SATB1_TARGETS_DN | NES DYSF SLC38A10 MMP10 ZBTB33 HTR2C ADAMTS1 TNC KAT6A NCOR1 SMARCA1 | 1.67e-04 | 388 | 195 | 11 | M15491 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | RAPGEF6 SPN MYCBP2 RGS19 CHD4 ADD1 HP1BP3 NFATC3 PKM JADE2 FOSB KAT6A AAK1 MSH3 MACF1 ROCK1 AKAP13 LSP1 | 1.68e-04 | 911 | 195 | 18 | M40038 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | HECW1 SPN IRAG1 PKM FLNB ZC3H12A FOSB TMEM115 NCOR2 UBE2O CTCF ANKRD11 | 1.69e-04 | 456 | 195 | 12 | M2094 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ABCA3 ADD1 SLC38A10 PTPRF C1S VCL ATRN FLNB SLC4A7 FOSB ABCC5 ANKRD11 | 1.73e-04 | 457 | 195 | 12 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ABCA3 ADD1 SLC38A10 PTPRF C1S VCL ATRN FLNB SLC4A7 FOSB ABCC5 ANKRD11 | 2.23e-04 | 470 | 195 | 12 | MM1053 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.37e-04 | 276 | 195 | 9 | M3063 | |
| Coexpression | MARTIN_INTERACT_WITH_HDAC | 2.43e-04 | 41 | 195 | 4 | M15154 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 2.54e-04 | 166 | 195 | 7 | M344 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | RGS19 ACBD3 ROCK2 COPB1 TNC KAT6A ABCC5 CREB1 CTCF SMARCA1 MACF1 TP53BP1 | 2.76e-04 | 481 | 195 | 12 | M3898 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B MYCBP2 CHD4 SLC38A10 PTPRF PKM FNIP1 BOD1L1 MGA SLC4A7 NCOR1 ANKRD11 MACF1 | 4.88e-12 | 195 | 198 | 13 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B MYCBP2 CHD4 SLC38A10 PTPRF PKM FNIP1 BOD1L1 MGA SLC4A7 NCOR1 ANKRD11 MACF1 | 4.88e-12 | 195 | 198 | 13 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 CHD4 HP1BP3 AHNAK ROCK2 FOSB KAT6A NCOR1 ANKRD11 MACF1 | 1.07e-08 | 184 | 198 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.25e-08 | 199 | 198 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-07 | 190 | 198 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 192 | 198 | 9 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 194 | 198 | 9 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 195 | 198 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.82e-07 | 199 | 198 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 200 | 198 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 200 | 198 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 200 | 198 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-07 | 200 | 198 | 9 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.76e-07 | 162 | 198 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-06 | 178 | 198 | 8 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 181 | 198 | 8 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 182 | 198 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 182 | 198 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.69e-06 | 183 | 198 | 8 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 185 | 198 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 185 | 198 | 8 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 186 | 198 | 8 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.91e-06 | 186 | 198 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.91e-06 | 186 | 198 | 8 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.15e-06 | 189 | 198 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-06 | 190 | 198 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 190 | 198 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 191 | 198 | 8 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.33e-06 | 191 | 198 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-06 | 192 | 198 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-06 | 192 | 198 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 193 | 198 | 8 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-06 | 193 | 198 | 8 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-06 | 194 | 198 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 194 | 198 | 8 | ba529c051f248d29f4222f4bc9801ba233859093 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 194 | 198 | 8 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.70e-06 | 88 | 198 | 6 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.70e-06 | 88 | 198 | 6 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.70e-06 | 88 | 198 | 6 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-06 | 196 | 198 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 2.82e-06 | 196 | 198 | 8 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.93e-06 | 197 | 198 | 8 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.93e-06 | 197 | 198 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-06 | 197 | 198 | 8 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.04e-06 | 198 | 198 | 8 | 88bb764b21ca50e56f6c536a2d61d35afd8c3f36 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 198 | 198 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-06 | 198 | 198 | 8 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 199 | 198 | 8 | e09bd3153dd60d06584707b259c78375b47415c8 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.15e-06 | 199 | 198 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 199 | 198 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.27e-06 | 200 | 198 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.27e-06 | 200 | 198 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 200 | 198 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.27e-06 | 200 | 198 | 8 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 200 | 198 | 8 | 8b80a65b69b36ed405214564b939452c90aa40d6 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-06 | 200 | 198 | 8 | 2bc7f462a551292de2501028164573935232f899 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.27e-06 | 200 | 198 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.27e-06 | 200 | 198 | 8 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.24e-06 | 162 | 198 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 169 | 198 | 7 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-05 | 178 | 198 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-05 | 178 | 198 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 1.75e-05 | 182 | 198 | 7 | cd6e3a9f4eb4fe73b28da61d1d35c64fd9ffa892 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 183 | 198 | 7 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.87e-05 | 123 | 198 | 6 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 184 | 198 | 7 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.88e-05 | 184 | 198 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 185 | 198 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-05 | 185 | 198 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-05 | 185 | 198 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 185 | 198 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.02e-05 | 186 | 198 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.16e-05 | 188 | 198 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 2.16e-05 | 188 | 198 | 7 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.16e-05 | 188 | 198 | 7 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 188 | 198 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 188 | 198 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.24e-05 | 189 | 198 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 198 | 7 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 198 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 198 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 189 | 198 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.24e-05 | 189 | 198 | 7 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 198 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.24e-05 | 189 | 198 | 7 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 189 | 198 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 190 | 198 | 7 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | KIAA0319L CXXC1 PTPRF ROCK2 FLNB ANK3 ARHGEF10L RABL6 SZRD1 TP53BP1 | 8.87e-06 | 197 | 197 | 10 | 7201_DN |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 8.87e-06 | 197 | 197 | 10 | 4501_DN | |
| Drug | IF-6 | 3.52e-05 | 22 | 197 | 4 | CID000043187 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.98e-05 | 188 | 197 | 9 | 4845_DN | |
| Drug | Thimerosal | PALD1 NES HECW1 LRRC37A2 ADGRB2 NASP CHD4 IRAG1 EPB41L4A VSIG10L BOD1L1 ALDH5A1 HTR2C ANK2 FOSB KAT6A UPF1 CREB1 PELP1 FLCN ARHGAP18 SPEN SNX2 TP53BP1 AHNAK2 | 4.27e-05 | 1199 | 197 | 25 | ctd:D013849 |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 4.50e-05 | 191 | 197 | 9 | 4283_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.69e-05 | 192 | 197 | 9 | 1068_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 4.69e-05 | 192 | 197 | 9 | 7536_UP | |
| Drug | SB204741 | 5.04e-05 | 24 | 197 | 4 | CID003277600 | |
| Drug | P6Chol | 5.16e-05 | 9 | 197 | 3 | CID000126085 | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | 5.29e-05 | 195 | 197 | 9 | 5117_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HG-U133A | 5.29e-05 | 195 | 197 | 9 | 1883_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A | 5.29e-05 | 195 | 197 | 9 | 1886_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 5.72e-05 | 197 | 197 | 9 | 4556_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | KIAA0319L HP1BP3 ALMS1 NFATC3 SLC4A7 ZBTB33 AKAP13 LSP1 SZRD1 | 5.72e-05 | 197 | 197 | 9 | 3311_UP |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; HL60; HG-U133A | 5.72e-05 | 197 | 197 | 9 | 1604_DN | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; HL60; HG-U133A | 5.72e-05 | 197 | 197 | 9 | 1789_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 5.95e-05 | 198 | 197 | 9 | 1588_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 198 | 197 | 9 | 7023_DN | |
| Drug | Aminohippuric acid [61-78-9]; Down 200; 20.6uM; PC3; HT_HG-U133A | 5.95e-05 | 198 | 197 | 9 | 6294_DN | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; HL60; HG-U133A | 5.95e-05 | 198 | 197 | 9 | 1443_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A | 6.19e-05 | 199 | 197 | 9 | 1970_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; HL60; HG-U133A | 6.19e-05 | 199 | 197 | 9 | 1387_DN | |
| Disease | Malignant neoplasm of breast | ABCA3 LRRC37A2 DYSF LRRC37A BOD1L1 TIMELESS MMP10 FLNB ANK2 NRCAM ADAMTS1 BCAR1 NCOR1 TGM2 KMT2D LIPE MACF1 LSP1 SPEN TP53BP1 | 2.20e-05 | 1074 | 190 | 20 | C0006142 |
| Disease | Prostatic Neoplasms | ERF ETV3 GRHPR MGA JADE2 KAT6A MSH3 BCAR1 NCOR1 KMT2D CTCF SMARCA1 AKAP13 SPEN | 5.01e-05 | 616 | 190 | 14 | C0033578 |
| Disease | Intellectual Disability | CHL1 KIFBP MAP1B PCDH12 NKAP ALDH5A1 CHD8 RABL6 FRY CTCF MACF1 | 1.64e-04 | 447 | 190 | 11 | C3714756 |
| Disease | Malignant neoplasm of prostate | ERF ETV3 GRHPR MGA JADE2 KAT6A MSH3 BCAR1 NCOR1 KMT2D SMARCA1 AKAP13 SPEN | 1.93e-04 | 616 | 190 | 13 | C0376358 |
| Disease | neuroimaging measurement | MAP1B RREB1 IRAG1 DYSF HP1BP3 TMEM218 WNK2 ANK3 SLC13A3 CREB1 NCOR1 PRG2 KIAA1755 MACF1 PAX7 ARHGAP27 ARHGAP18 SZRD1 | 2.03e-04 | 1069 | 190 | 18 | EFO_0004346 |
| Disease | osteopontin measurement | 2.45e-04 | 4 | 190 | 2 | EFO_0021776 | |
| Disease | Profound Mental Retardation | 2.91e-04 | 139 | 190 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.91e-04 | 139 | 190 | 6 | C0025363 | |
| Disease | Mental deficiency | 2.91e-04 | 139 | 190 | 6 | C0917816 | |
| Disease | cortical surface area measurement | PALD1 MYCBP2 CALHM1 RREB1 IRAG1 DYSF PTPRF ARHGAP31 TAF5 WNK2 ROCK2 FLNB ANK3 COPB1 NCOR1 KIAA1755 MACF1 PAX7 ARHGAP27 MCTP2 | 4.51e-04 | 1345 | 190 | 20 | EFO_0010736 |
| Disease | fat body mass | 5.38e-04 | 217 | 190 | 7 | EFO_0005409 | |
| Disease | glial fibrillary acidic protein measurement | 6.08e-04 | 6 | 190 | 2 | EFO_0020404 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 6.08e-04 | 6 | 190 | 2 | C1834523 | |
| Disease | Colorectal Carcinoma | CHL1 ERICH1 ABCA3 MAP1B SLC12A5 DNAH8 ANK2 NRCAM ABCC5 ARHGEF10L TGM2 PRG2 FLCN | 6.65e-04 | 702 | 190 | 13 | C0009402 |
| Disease | epilepsy (implicated_via_orthology) | 6.78e-04 | 163 | 190 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | total blood protein measurement | RREB1 DYSF NFATC3 HYOU1 CAST NCOR2 KMT2D MACF1 ROCK1 SLC37A4 | 7.04e-04 | 449 | 190 | 10 | EFO_0004536 |
| Disease | Mood Disorders | 7.93e-04 | 168 | 190 | 6 | C0525045 | |
| Disease | MICROPHTHALMIA, ISOLATED 1 | 8.48e-04 | 7 | 190 | 2 | C1855052 | |
| Disease | Gonadal dysgenesis XX type deafness | 8.48e-04 | 7 | 190 | 2 | C0685838 | |
| Disease | level of oxylipin in blood plasma | 8.48e-04 | 7 | 190 | 2 | OBA_2050338 | |
| Disease | Microphthalmos, Autosomal Recessive | 8.48e-04 | 7 | 190 | 2 | C4551977 | |
| Disease | clusterin measurement | 8.48e-04 | 7 | 190 | 2 | EFO_0007655 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 8.48e-04 | 7 | 190 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | MASA syndrome (implicated_via_orthology) | 8.48e-04 | 7 | 190 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | breast cancer anti-estrogen resistance protein 3 measurement | 1.13e-03 | 8 | 190 | 2 | EFO_0008040 | |
| Disease | Cocaine Abuse | 1.42e-03 | 127 | 190 | 5 | C0009171 | |
| Disease | Distal arthrogryposis | 1.44e-03 | 9 | 190 | 2 | cv:C0265213 | |
| Disease | Cataract microcornea syndrome | 1.44e-03 | 9 | 190 | 2 | C1861829 | |
| Disease | uveitis | 1.44e-03 | 9 | 190 | 2 | EFO_1001231 | |
| Disease | eosinophil count | KIFBP RAPGEF6 DYSF SAMD15 GTF3C4 FNDC1 CFAP92 FNIP1 AP1G2 C1S ABCC5 ARHGEF18 KANSL3 NCOR2 PELP1 GOLPH3L PRG2 ANKRD11 AKAP13 TP53BP1 | 1.55e-03 | 1488 | 190 | 20 | EFO_0004842 |
| Disease | schizophrenia (is_implicated_in) | 1.64e-03 | 78 | 190 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Schizophrenia | CHL1 RAPGEF6 ESS2 CHD4 SLC12A5 GJA8 HTR2C ANK3 GRM5 CREB1 TGM2 CTCF ARHGAP18 MCTP2 | 1.83e-03 | 883 | 190 | 14 | C0036341 |
| Disease | Mammary Neoplasms | LRRC37A2 LRRC37A NRCAM ADAMTS1 NCOR1 TGM2 KMT2D CTCF LSP1 TP53BP1 | 2.31e-03 | 527 | 190 | 10 | C1458155 |
| Disease | Fetal Alcohol Spectrum Disorders | 3.07e-03 | 13 | 190 | 2 | C2985290 | |
| Disease | Connective Tissue Diseases | 3.07e-03 | 13 | 190 | 2 | C0009782 | |
| Disease | hypertension | 3.88e-03 | 307 | 190 | 7 | EFO_0000537 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.89e-03 | 49 | 190 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 3.93e-03 | 477 | 190 | 9 | C0005586 | |
| Disease | anemia (implicated_via_orthology) | 4.10e-03 | 15 | 190 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | body mass index, fasting blood glucose measurement | 4.36e-03 | 51 | 190 | 3 | EFO_0004340, EFO_0004465 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 4.36e-03 | 51 | 190 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Neuralgia, Supraorbital | 4.66e-03 | 16 | 190 | 2 | C0038870 | |
| Disease | DiGeorge Syndrome | 4.66e-03 | 16 | 190 | 2 | C0012236 | |
| Disease | Neuralgia | 4.66e-03 | 16 | 190 | 2 | C0027796 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 4.66e-03 | 16 | 190 | 2 | C0795907 | |
| Disease | Neuralgia, Atypical | 4.66e-03 | 16 | 190 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 4.66e-03 | 16 | 190 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 4.66e-03 | 16 | 190 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 4.66e-03 | 16 | 190 | 2 | C0423711 | |
| Disease | T-Cell Lymphoma | 4.66e-03 | 16 | 190 | 2 | C0079772 | |
| Disease | Seasonal Affective Disorder | 4.66e-03 | 16 | 190 | 2 | C0085159 | |
| Disease | Paroxysmal Nerve Pain | 4.66e-03 | 16 | 190 | 2 | C0751373 | |
| Disease | Nerve Pain | 4.66e-03 | 16 | 190 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 4.66e-03 | 16 | 190 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 4.66e-03 | 16 | 190 | 2 | C0042656 | |
| Disease | Shprintzen syndrome | 4.66e-03 | 16 | 190 | 2 | C0220704 | |
| Disease | coronary artery disease | KIFBP MAP1B RGS19 IRAG1 EPB41L4A FNDC1 EIF2B2 C1S ALDH5A1 WNK2 PPP1R9A AAK1 BCAR1 TTC29 AKAP13 MCTP2 | 4.67e-03 | 1194 | 190 | 16 | EFO_0001645 |
| Disease | iritis | 5.26e-03 | 17 | 190 | 2 | EFO_1000997 | |
| Disease | Fetal Alcohol Syndrome | 5.26e-03 | 17 | 190 | 2 | C0015923 | |
| Disease | Epilepsy | 5.48e-03 | 109 | 190 | 4 | C0014544 | |
| Disease | urate measurement | RREB1 DYSF CXXC1 GJA8 PTPRF NFATC3 MYO18B REXO4 U2SURP AAK1 GOLPH3L AKAP13 PAX7 | 5.49e-03 | 895 | 190 | 13 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDEDEEPKSCLVGPE | 1276 | O60241 | |
| EKEAAPDAGAEPITA | 286 | Q8N163 | |
| EDEEDGEVFKTPRAP | 446 | P50548 | |
| EDPTPAGEEDVKDAR | 256 | Q86X53 | |
| PLSPDVEEEDDDLGK | 26 | P48751 | |
| EEEGPFSLPEEERKV | 791 | Q6ZSZ5 | |
| SGEEAKPEVEVEPAK | 181 | Q9HCE6 | |
| EDELPSVRPEEEGEK | 486 | Q9HCK8 | |
| EPSGEPKLDVALEAA | 2206 | Q6UB99 | |
| PVVESEKGDAPDLVD | 246 | Q6UX04 | |
| VEVKKEPDAEPAEGE | 686 | P49711 | |
| VPEGSDKVAEDEFDP | 906 | Q2M2I8 | |
| EADDFDPGKKVEVEP | 106 | Q9H8M2 | |
| SVSKDVPDGPLLREE | 311 | P56945 | |
| EEKEDPSPVSDVPGV | 496 | Q86TY3 | |
| EVTEDSEDRPGKEPS | 446 | P41162 | |
| EPVIEKASDNEPGIE | 421 | P28335 | |
| AQDAPLPKGADLIEE | 1236 | Q12802 | |
| PEEALKVSAVSGPAD | 831 | Q8TCU4 | |
| PLVERDGPQADEEAK | 586 | O75843 | |
| KPRAVAGKEEEDSDP | 496 | Q99758 | |
| GPEVDVNLPKADVDI | 766 | Q09666 | |
| DVTAPDVSIEEPEGK | 786 | Q09666 | |
| KVDIEAPDVSLEGPE | 1161 | Q09666 | |
| ADIDVSGPKVDVEVP | 1281 | Q09666 | |
| DVDIKGPKVDIDAPD | 1686 | Q09666 | |
| GPKVDIDAPDVEVHD | 1691 | Q09666 | |
| KGEIDASVPELEGDL | 1796 | Q09666 | |
| DVKGPFVEAEVPDVD | 1816 | Q09666 | |
| GPKVDVEVPDVSLEG | 2081 | Q09666 | |
| DVDVSGPKVDVEVPD | 2271 | Q09666 | |
| GPKVDVEVPDVSLEG | 2276 | Q09666 | |
| EGPEVDVNLPKADVD | 2526 | Q09666 | |
| PKADIDVSGPKVDVE | 2791 | Q09666 | |
| GPEVDVNLPKADVDV | 2911 | Q09666 | |
| LDVSGPKVDIDVPDV | 3051 | Q09666 | |
| EGPEVDVNLPKADLD | 3166 | Q09666 | |
| DVDAPDIDIHGPDAK | 3261 | Q09666 | |
| GPDVDVNLPKADLDV | 3821 | Q09666 | |
| ADLDVSGPKVDIDVP | 3831 | Q09666 | |
| LDVSGPKVDVDVPDV | 3961 | Q09666 | |
| DIKGPKVDIDAPDVD | 4036 | Q09666 | |
| KVDIDAPDVDVHGPD | 4041 | Q09666 | |
| EGPEVDVNLPKADID | 4076 | Q09666 | |
| DLDVSGPKVDIDVPD | 4216 | Q09666 | |
| EISGPKVDIDAPDVS | 4346 | Q09666 | |
| KVDIDAPDVSIEGPD | 4351 | Q09666 | |
| GPEIDIKGPSLDIDT | 4416 | Q09666 | |
| DPKVDIDVPDVDVQG | 4631 | Q09666 | |
| EGPDVDVSLPKADID | 4796 | Q09666 | |
| APTTPDGAEEEREKL | 276 | Q8IU99 | |
| AEEEADPTLTGPRKQ | 361 | Q9ULG3 | |
| AVGKVEELIESEAPP | 6 | Q96B23 | |
| KLAEGEEEKPEPDIS | 56 | Q5SSJ5 | |
| IKPEAPGEDESLEEL | 31 | Q5JQD4 | |
| SEEEAEVAAPTKGPA | 471 | Q3YEC7 | |
| VDDEPRPTGKAETED | 201 | Q9UHI8 | |
| PEVGEEELVSVPDAK | 686 | Q9ULE6 | |
| EGSDVESEPDLPLKR | 201 | P23759 | |
| EGPLDPEEDLSVKQL | 1016 | Q9NPG4 | |
| ELVKAAEEEPGEPFE | 1536 | Q01484 | |
| ADDFPGVEPKVDAVL | 426 | P09238 | |
| EDESKLDPGAAEQVP | 1036 | P20585 | |
| EKEEETAAAPPVEEG | 826 | Q9Y618 | |
| FEEPPKAVELEGLAA | 976 | Q96RG2 | |
| AGPEAAAAKPDLEEL | 1146 | P41594 | |
| VEKSLEGPLAPSTDE | 16 | Q8WZ60 | |
| KEDAAEETVKPGPEE | 1041 | P78559 | |
| EETVKPGPEEGTLEK | 1046 | P78559 | |
| EREVTKGPAESPDEG | 881 | P46821 | |
| LEVTVFDEDGDKPPD | 571 | Q6DN12 | |
| EATDSFPRGPVDEKV | 101 | Q96LZ2 | |
| EDKILNRDPGDSEAP | 1676 | A6NM11 | |
| EDKILNRDPGDSEAP | 1676 | A6NMS7 | |
| PDPEIQSVKDETFGE | 1121 | O00533 | |
| EEEKAPVLPESTEGR | 306 | Q8NFG4 | |
| PKELEREESGAAESP | 171 | Q96EK9 | |
| PDVKPDLEDVDGVLF | 651 | Q8IWI9 | |
| DSEPGKILNLVSDPE | 721 | P19823 | |
| IPVKDDPDEGEARLE | 446 | Q86T24 | |
| DPDEGEARLENEIPK | 451 | Q86T24 | |
| IEIAPDDPSRKIDGD | 401 | Q92823 | |
| EEKEETIDAGPPTAS | 491 | Q6PXP3 | |
| GPSLKGEEEPLVASE | 366 | P16150 | |
| ADAGPDKELTLPVDS | 601 | Q8IZA0 | |
| EEKAALPEASAGSPE | 536 | Q5JYT7 | |
| EDLILTEPEPEHTGK | 156 | Q9Y2Z2 | |
| AAKADEEPTPADGRI | 81 | Q96AT1 | |
| GEAPASTKEEPLEEE | 476 | Q76N89 | |
| ETDEEPPDLIGGSIK | 1336 | O75882 | |
| KSPRGADEPEDSELE | 1331 | Q96Q04 | |
| EEGEDEASLDPLKPC | 106 | Q5VYM1 | |
| EQEKGLPSELSPAIE | 471 | Q9Y6F6 | |
| EPTEPSQAGEDLEKV | 376 | Q9NQC1 | |
| SPLPGDAVKDLDIID | 886 | O75369 | |
| PEDVITGAFKVLDPE | 96 | Q96A32 | |
| EAGELKPEEEITVGP | 496 | P53618 | |
| KRLVDNIFPEDPEDG | 16 | Q9Y2G0 | |
| SDEDEEKGAVVPPVH | 691 | Q12996 | |
| TGDEPEDSVFEVPKI | 2746 | Q96JB1 | |
| EEDPEEVKTSLGVPQ | 161 | Q9UHL3 | |
| PEVGDEEALRPLTKE | 681 | P48681 | |
| VLASEGLEAPPSEKE | 1336 | P48681 | |
| ESDPVSLEREDKVPG | 1501 | P48681 | |
| LPGAAVDLPAVSEKD | 211 | P14618 | |
| PEAAEEALENGPKES | 351 | Q9H3P7 | |
| PPTLLEEETEDGSDK | 1061 | Q8IZL8 | |
| SLVEGEKEEEEETPP | 601 | Q96MC2 | |
| EAESLDPTVKPVDVG | 296 | P49321 | |
| PVDVGGDEPEEKVVT | 306 | P49321 | |
| PAEAEGVPLVVDKDV | 2141 | Q9UPN3 | |
| AEVRDLPGSAPAKED | 236 | P53539 | |
| GAKTLPEDEETPEQE | 31 | P13727 | |
| PTREDVKEEPGVQES | 1336 | Q92794 | |
| LDSDERPSPEEEEGK | 551 | O15440 | |
| ENPSATLEDLEKPGV | 271 | Q92900 | |
| TLEDLEKPGVDEEPQ | 276 | Q92900 | |
| EDKPFEETGVEPVLE | 961 | Q8NFC6 | |
| PSLVEEIPLDKDDLG | 36 | O43826 | |
| AGEEEEKEPLPSLDV | 136 | Q96DF8 | |
| EDEGAVASSTVKEPP | 256 | Q9P0U4 | |
| PGEQVELKEEAEAPV | 616 | Q9Y4L1 | |
| GQTEDAEPISEPEKV | 946 | Q9Y4L1 | |
| AEPISEPEKVETGSE | 951 | Q9Y4L1 | |
| PPVQSLKGEDAEESL | 181 | Q53T59 | |
| ADAPVLGSPEKEEAA | 366 | O15234 | |
| RKLEAAEEPPGEELS | 561 | Q49AN0 | |
| SPASPKGEEEEREVQ | 501 | Q9P218 | |
| HGDEEDEKPLPATVV | 876 | Q4ZHG4 | |
| AEEDEIPFPGSKLIE | 971 | Q8TF40 | |
| VPEGEKVETPGVDKE | 366 | P48165 | |
| DSIRNEPFKIPEDDG | 236 | Q99418 | |
| SDEPIPAKELERGVA | 36 | Q9UBQ7 | |
| DLVELDPEVEGTKPS | 256 | Q9H4A5 | |
| IPESIENGKVEDPES | 361 | P09871 | |
| VDLSKVPSPLTDEEG | 586 | Q5T0F9 | |
| PQDLKELGDDSLPAE | 886 | Q12955 | |
| LFLTPEPGAEAKEVE | 51 | Q8TDM0 | |
| APGVPRIEEEKSEEE | 131 | P16220 | |
| DSSKPIGPDDAIDAL | 221 | P20810 | |
| EPATLKGTVPDDAVE | 421 | P20810 | |
| SLKPSEAPELDEDEG | 66 | P33241 | |
| FVPISSEPPEEGEKE | 606 | Q9P2N6 | |
| SEPPEEGEKEDLRVQ | 611 | Q9P2N6 | |
| AKPEPVSVDVGEDAS | 316 | Q6UWL6 | |
| PSSPEDEVKDREGDV | 1381 | Q5TBA9 | |
| PEEVLPFTEGDILEK | 291 | P49770 | |
| GPSETDDVDEKQPLS | 256 | P78347 | |
| ASEDEKVVVEPPEGE | 1601 | Q14839 | |
| VDPSGLSEEQLKEIP | 561 | Q9HCS5 | |
| KSSEEAGLEPPEETQ | 271 | Q9P1V8 | |
| TEAKDHPGETEVPLD | 201 | Q8WWT9 | |
| ALEEAGDLPEDPQKV | 566 | Q9HBR0 | |
| VAGEPLPVDSEKDIF | 306 | P06746 | |
| EIEEEPAGAVKPSKA | 491 | O75923 | |
| SPGEDVLIDIDDKEP | 1451 | O75923 | |
| AEELPVETPKRAGAE | 281 | Q5FWE3 | |
| VKALLGPAPEDEDER | 46 | Q96EK5 | |
| EEPALPSLEGVSEKQ | 346 | Q06587 | |
| DPATPAKSDLEDLEE | 281 | P0C7A2 | |
| FLLPPEDAGEEAEAK | 911 | Q05469 | |
| RTKAEEPSDLIGPEA | 281 | Q8N5F7 | |
| GEEFEKEIRTPEDLP | 901 | P10586 | |
| LNVPEETAGDSEEKP | 976 | Q9H2X9 | |
| PEGEGETDPEKVHLT | 1016 | Q9H2X9 | |
| SKEETAEAEPSGPEV | 891 | O60391 | |
| AKPDEVVVDIEDGPK | 1241 | Q2WGJ9 | |
| PADIEAAIGPEAAKI | 201 | Q9GZR2 | |
| DTDISIKPEGVREPD | 226 | Q16799 | |
| PEAAEITASVKDLPG | 141 | Q7L099 | |
| KEPVGDDESVPENVL | 71 | P49591 | |
| EEQTEVAVKLEPEGP | 6 | Q15542 | |
| RILGSASPEEEQEKP | 101 | Q7Z422 | |
| EAEKQITGPEEADRP | 6 | P49795 | |
| SNGPKPTEVVLDDDR | 56 | O60749 | |
| SPEAVGPELEAEEKL | 81 | Q96N64 | |
| EDEGEVSLPEQPKVT | 451 | Q17RP2 | |
| KPGDHDPETLEAIAE | 211 | Q96Q11 | |
| ESSEGLDPKDATDPV | 1461 | Q8TEU7 | |
| PGPDEEAVVDLGKTS | 11 | Q9Y6M7 | |
| GPLAPVIKFDTEEEA | 441 | P51649 | |
| DGAEPLTPEETEEKE | 836 | P28370 | |
| KGSDLDPEEPIKVEE | 106 | Q96BD8 | |
| PIEDSSPEKGREEAA | 1191 | O75376 | |
| SPPEEKVPAELDEVG | 466 | Q6ZUM4 | |
| AAAEPLLAAEKAEEP | 21 | Q587I9 | |
| GPKSDDDGFEIVPIE | 641 | Q8IY81 | |
| DDGFEIVPIEDPAKH | 646 | Q8IY81 | |
| KEIIPGNLEDPSEFE | 751 | Q562F6 | |
| PREPESEGIKLSADV | 6 | Q96T21 | |
| KSEEPPGTELQRDTE | 596 | Q96T21 | |
| LDKASTSLPGEPEVE | 471 | Q6ZUB1 | |
| GDAEPTPEQEEKALL | 3916 | O75592 | |
| AKVEGEESPAEPAAT | 421 | O75688 | |
| PVGPATGEAKLSEEE | 116 | Q9Y2V3 | |
| PPQSEAELELKEGDI | 841 | Q7Z6J0 | |
| IDATPIDDLDGVPIK | 716 | O15042 | |
| EATTPLADEGRAPKD | 5621 | Q8IVF2 | |
| IKLEEDLVPEPTTGD | 616 | P35611 | |
| DGEDEPTLVQKEPVE | 251 | Q16740 | |
| PSEDDEAEELKALSP | 516 | Q14028 | |
| QPSEEDPDEGIKDLV | 136 | Q9HAE3 | |
| EQISADPDKPLADGI | 426 | Q7KZ85 | |
| EEQKTVEIPDPVEAG | 631 | P21980 | |
| EGPEEEPLAEREVKA | 1146 | O15417 | |
| EEEDAVGKEPLKAAP | 1151 | Q9UNS1 | |
| DEKHSPEVEAGEPSL | 471 | Q15468 | |
| PEKENEGDITIFPES | 1241 | Q15468 | |
| PEEEKEGSDLRPVVI | 126 | Q5D1E8 | |
| EGPERSQEEPKEGET | 1286 | Q9C0A1 | |
| PEQPADGVSAVDLEK | 966 | Q96T58 | |
| EPVLPEDTTTEEKRG | 341 | Q15772 | |
| VVEDEAKAEPKEPDG | 206 | A8MU46 | |
| EAPAEKLAEETEGPS | 1461 | Q92766 | |
| PAEEENGLKEVPEAS | 116 | O60224 | |
| EVEEGVPPTSDEEKK | 41 | Q9UHP9 | |
| VSTKPEPEDDAEEGL | 146 | Q6VEQ5 | |
| EEESGAKVDSPLPSD | 311 | Q12893 | |
| VSTKPEPEDDAEEGL | 146 | A8K0Z3 | |
| VDLESASGEKDLAPP | 66 | P24821 | |
| EVDGKAIPDLTAPVA | 31 | P18206 | |
| EEEAGSTAPEPREAK | 1776 | Q9H5I5 | |
| PVAPEDKGVVISEEA | 766 | Q9C0C9 | |
| ADKVFPSLDEEVPPA | 31 | Q5BVD1 | |
| DGATVSIKPEPEDRE | 1006 | Q12968 | |
| DIEDDKGDVETFPIP | 386 | O75116 | |
| PEEEKPLGAETSAAS | 536 | Q2M1Z3 | |
| EIPETPCESQGEELK | 666 | Q12888 | |
| DIEEADPPQLGDFTK | 576 | Q9H0V1 | |
| KEGDVEEPTDDSLPT | 641 | Q9UKN8 | |
| DEASNLVGEEKLIPP | 206 | Q8N392 | |
| TELEGPSQPALEKDA | 461 | Q8IUG5 | |
| LEEDKGEEETFPIPK | 371 | Q13464 | |
| KESRGNIEPDPVTEE | 431 | Q8NA56 | |
| APKIPEGEKVDFDDI | 56 | P45378 | |
| GEFPAPEVEVKIVDD | 61 | A2RU14 | |
| EDALKVDQGPSRDIP | 6 | Q8NEE8 | |
| VQPKAPETEEGAAEL | 306 | Q86VR7 | |
| VRKEDEGAAEAKPEP | 151 | Q9Y3S1 | |
| PAEGKFTEAIVDAEP | 76 | Q7Z7G0 | |
| APVPDGESEKTVEES | 171 | Q9Y3C0 | |
| EVGASKPEGIDSRPE | 126 | P04004 | |
| GPDSLARSTEKPEEE | 326 | P58304 | |
| ECEIKLEGPVSPDVE | 1661 | O14686 | |
| ELFPVELEKDEDGLG | 501 | Q9ULJ8 |